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Abstract
Non-secretors of ABO blood group antigens are over-represented among patients
with disease due to Neisseria meningitidis and among carriers of this bacterium.
On the basis of the known differences between secretors and non-secretors, two
hypotheses have been suggested to explain this epidemiological observation. The
first suggests that the H blood group determinant is a binding site for bacteria.
It is proposed that the presence of this structure in body fluids of secretors can
block the attachment of the bacteria to cells, reducing colonization. The second
hypothesis suggests that Lewis3 (Lea) blood group determinants, found mainly
on cells of non-secretors, acts as a receptor for the bacteria. The aim of this
study was to investigate whether Lea or H determinants might be receptors for
N. meningitidis.
As a preliminary step, the differential distribution of H determinants in saliva
and on cells of secretors and non-secretors was studied. An enzyme linked im-
munosorbant assay (ELISA) was developed for the measurement of H determi¬
nants in secretions. With this method, the level of H determinants in secretions
of secretors was found to be higher than in secretions of non-secretors. The
level of H determinants on the surface of epithelial cells was determined by
flow cytometric analysis. Between 3.5-6 times more H epitopes were detected
on epithelial cells from secretors compared with cells from non-secretors. With
the same technique, uptake of antigens containing H Type 1 determinants from
saliva onto epithelial cells was demonstrated.
The level of attachment of N. meningitidis to epithelial cells obtained from
secretors and non-secretors was studied by flow cytometry. At a low ratio of
bacteria to epithelial cells, more bacteria bound to cells from non-secretors com-
v
pared with cells from secretors. The finding that the level of H determinants
did not positively correlate with the amount of bacteria attached suggests that
H is not a receptor for the bacteria.
A possible role for the Lea determinant as a binding site for N. meningitidis
was then investigated. The binding of meningococci to cells of non-secretors
was inhibited by preincubation of the bacteria with affinity purified molecules
containing Lea determinants. Using an ELISA developed for the detection of
Lea determinants, a number of N. meningitidis isolates were found to adsorb
affinity purified molecules containing Le° epitopes. These results support the
hypothesis that Lea is a receptor for the bacteria.
Finally, an attempt was made to identify the structure on the bacteria and
the carbohydrate sequence of the blood group determinant that interacts in the
attachment process. The binding of synthetic glycoproteins containing blood
group determinants to preparations of outer membrane proteins from N. menin¬
gitidis strain (C:2b:Pl.2) was demonstrated. Human serum albumin conjugated
with Type 1 blood group structures (precursor chain, H, Lewis" and Lewis6)
were found to bind to a preparation of the outer membrane proteins of N.
meningitidis. Precursor Type 1 chain is the carbohydrate structure common
to all glycoconjugates used, suggesting that this structure is part of the bacte¬
rial binding site. Greater accessability of the precursor Type 1 chain receptor
on antigens of non-secretors compared with secretors, could contribute to the
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Studies of the associations between blood group phenotypes and susceptibility
to disease began soon after the discovery of the ABO blood groups at the begin¬
ning of this century. These studies have been reviewed in "Blood Groups and
Diseases" (Mourant et al., 1978) and more recently by Bird (1983) and Blackwell
(1989b).
A phenomenon related to the blood group systems is the secretion of A,
B and H blood group structures into body fluids. This genetically determined
feature also influences the type of Lewis blood group determinant present on
cells and in secretions. The ability to secrete the ABH blood group antigens
was found to be a susceptibility factor for several diseases reviewed by Blackwell
(1989b). Over the last few years a number of epidemiological surveys have
demonstrated that non-secretors of the ABH blood group antigens axe more
susceptible to infections and to some autoimmune conditions. This study was
initiated to examine hypotheses suggested to explain the association of non-
secretion of blood group antigens with meningococcal disease and carriage of
these bacteria.
In this chapter four general areas are reviewed to provide necessary back¬
ground for the approach used in this study: 1) biochemistry and genetic control
of blood group antigens related to secretor status; 2) blood groups and disease
susceptibility; 3) the epidemiology and pathogenesis of meningococcal disease;
4) hypotheses proposed to explain the increased susceptibility of non-secretors
to infectious diseases. The aims of this study, to examine two hypothesis relat¬
ing to colonization of epithelial surfaces by N. meningitidis, are summarised at
the end of this chapter.
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1.1 The ABO and Lewis Blood Group Systems
and Secretor Status
1.1.1 Introduction
Agglutination of red blood cells from one species by serum from another was
discovered by Londois in 1875 (reviewed by Race and Sanger, 1975). Twenty five
years later, Landsteiner noted that human red blood cells can be agglutinated
by serum from another individual. This observation led him to the discovery of
the ABO blood group system (see Mourant et al., 1978). Within a few years
studies showed that humans could be divided into four groups (A, B, O and
AB) according to the reaction of their red blood cells with normal human sera.
This information was later adopted for blood transfusion purposes which started
at the end of World War I. In 1910, Dunger and Hirszfeld demonstrated that
the blood group antigens were inherited as Mendelian characters (reviewed by
Mourant et al., 1978).
In 1946, Mourant reported the discovery of anti-Lea. The antibody described
reacted with red cells and was recognized as defining a new antigen. In 1948,
Andersen described the first example of anti-Le6 (see Race and Sanger, 1975).
It is now known that these antigens are not the products of allelic genes, but a
result of the interaction between two gene products.
In this part of the introduction the biochemistry and genetics of the ABH
and the Lewis blood group systems will be reviewed as they are essential for
examination of the association between secretion of blood group antigens and
disease.
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1.1.2 The ABO System
Biochemistry
The ABH blood group determinants are carbohydrate chains carried on macro-
molecules, mainly glycoproteins in secretions and glycolipids and glycosphin-
golipids on cell surfaces. The carbohydrate moiety of all blood group antigens
is composed of a basic precursor chain to which different monosaccharides are
added by different glycosyltransferases. These enzymes are suggested to be
the primary protein product of the blood group genes. The monosaccharides
added by the glycosyltransferases defines the serological properties of the differ¬
ent blood group determinants.
Four types of precursor chains that carry the ABH antigens have been de¬
scribed (Rege et al., 1963; Donald, 1981; Bremer et al., 1984). Of these, antigens
derived from Type 1 and Type 2 precursor substances appear to carry most of
the ABH antigens on cells and in secretions. Type 1 chains have a D-galactose
residue joined by a /? 1-3 linkage to N-acetyl-D-galactosamine , whereas the
Type 2 chain has a /3 1-4 linkage between these two sugars (Figure 1.1). The
structure of H (Rege et al., 1964; Lloyd et al., 1966), A and B (Painter et al.,
1965; Lloyd et al., 1966) determinants based on Type 1 and Type 2 chains are
shown in Figure 1.2. H Type 1 and 2 are composed of the respective precursor
chains with an additional L-fucose joined to the C2 position of the terminal D-
galactose residue. The A and B determinants are based on the H structure with
an additional monosaccharide: N-acetyl-D-galactosamine in A determinants and
D-galactose in B determinants. The biochemical pathways by which the ABH
antigens are formed is shown in Figure 1.3. Each one of the blood group genes










Figure 1.1: Diagram of the two types of carbohydrate chain endings which
form the basis of A, B and H determinants on cells and in secretions.
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Oi-f ucose On-Acetylgalactosamine Od-galactose
Figure 1.2: Structure of H, A and B determinants based on Type 1 and
Type 2 carbohydrate chains. The symbols for the constituents of precursor
chains are as in Figure 1.1.
6










Figure 1.3: Biochemical pathways for the formation of H, A and B struc¬
tures. Symbols as in Figures 1.1 and 1.2. The H transferase (H) specifically
transfers fucose from guanosine diphosphate (GDP) L-fucose to precursor chain.
The A transferase (A) specifically transfers N-acetylgalactosamine from uridine
diphosphate (UDP) N-acetylgalactosamine to the H structure. The B transferase
(B) specifically transfers galactose from uridine diphosphate (UDP) D-galactose
to the H structure.
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blood group determinant. These enzymes catalyze the transfer of a specific nu¬
cleotide sugar to an acceptor structure on a glycolipid or glycoprotein molecule
(Watkins, 1967).
In secretions and in endodermally derived tissues such as lining epithe-
lia, the blood group determinants are carried mainly on Type 1 chains (Oriol
et al., 1986). A prime necessity for the formation of the terminal disaccha-
ride of a Type 1 structure is the expression of an N-acetylglucosamine (3-3-
galactosyltransferase. This enzyme has not been isolated or purified, and very
little is known about its distribution in human tissues.
The endogenously produced ABH antigens expressed on erythrocytes are
based on Type 2 chains. Small quantities of ABH determinants carried on Type
1 chain can be found on red blood cells. These antigens are adsorbed onto the
surface of the cells from the plasma (Tilley et al., 1975).
Blood group determinants are known to be carried on a variety of lipid and
protein carriers. They have been reported to appear as part of the epidermal
growth factor receptor (Parker et al., 1984) and on various hydrolytic enzymes
(Green et al., 1988). The carbohydrate chain carried on these macromolecules
can vary in length and complexity from a short simple chain to complex highly
branched structures. Variation in the carrier (lipid/protein) molecules and in the
carbohydrate residues, give rise to a wide range of molecules expressing blood
group determinants. The molecular weight of antigens carrying blood group
determinants in secretions has been estimated to range from 2xl05 to several
million daltons (Watkins, 1980).
The term blood group antigen is used to refer to a group of molecules, all
carrying the same carbohydrate structure at the end of the oligosaccharide chain
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and able to induce an allogeneic immune response to this determinant. A great
variety of molecules can carry the same carbohydrate structure; therefore, each
one of these molecules can be considered as a separate antigen sharing one
antigenic determinant. To be accurate, the term blood group determinant should
be used to describe a carbohydrate structure responsible for the production of
isohaemagglutinins.
Genetic control
The ABO locus present on chromosome 9 (Westerveld et al., 1976) was first
thought to contain three major alleles: A, B and O (reviewed by Watkins, 1980).
It is now known that there are two A alleles encoding for A\ and A2, the two
subgroups of blood group A (reviewed by Watkins, 1980). One of the four alleles
is transferred to the offspring from each parent. The O allele does not give rise
to a functional product therefore the three functional alleles are A\, A2 and
B. Each gene codes for a glycosyltransferase that adds the appropriate sugar
for the formation of the specific blood group determinant. The term H was
introduced by Morgan and Watkins (1948) to describe the antigen found in all
ABO phenotypes. This substance is synthesised by a glycosyltransferase coded
by the H gene. The H gene is situated at a site independent of the ABO locus
and produces the substrate for the products of the A and B genes (Watkins and
Morgan, 1955). The h gene is a rare silent allele of H. Individuals homozygous
for h (hh) are the para-Bombay phenotype in whom blood group antigens are not
expressed in tissues of ectodermal origin. Since the H determinant is the acceptor
for the A and B enzymes, in para-Bombay individuals these determinants will
not be formed on Type 2 precursor chains, although the A and B transferases
















Figure 1.4: Diagram showing the production of A, B and H determinants
on Type 2 chains. Symbols as in Figures 1.1 and 1.2. The arrows represent the
reactions possible in individuals possessing the genes indicated by the letters.
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The ability to produce blood group determinants in secretions is determined
by allelic genes, Se and se , on chromosome 19 and is inherited as a Mendelian
dominant character (see Watkins, 1980). An individual homozygous for the
Se gene (SeSe) or heterozygous (Sese) is a "secretor"; whereas, an individual
homozygous for the silent allele (sese) is a "non-secretor". Among Europeans,
about 80% are secretors and 20% are non-secretors. These percentages can vary
among different ethnic groups (Race and Sanger, 1975).
Two hypotheses have been proposed to explain the role of the Se gene in
determining secretor status. On the basis of biochemical studies it has been
suggested that the Se gene is a regulatory gene, controlling the expression of the
H gene in epithelial tissues (Watkins, 1959). This hypothesis received support
from the observation that the a-2-fucosyltransferase (the enzyme coded by the
H gene) is strongly expressed in glandular and mucosal tissues from secretors
and only minimally in those of non-secretors (Ginsburg, 1972).
A second hypothesis more recently proposed by Oriol et al., (1981) suggests
that the Se gene is a structural gene. This "two structural gene" model states
that a second o:-2-fucosyltransferase, coded by the Se gene, is responsible for the
formation of the H structure in tissues of endodermal origin. The enzymes coded
by the H and Se genes transfer L-fucose to a terminal /^-galactose to form the
H determinant; but they differ in the precursor chain used as an acceptor. It is
suggested that the enzyme coded by the H gene preferentially fucosylates Type
2 precursor chain; whereas the Se gene product has a higher affinity for the Type
1 precursor chain than for Type 2. This proposal is supported by several stud¬
ies. In the first, fucosyltransferase from human milk, which is associated with
possession of the Se gene, showed 20 fold higher affinity for Type 1 compared
with Type 2 chains (Kumazaki and Yoshida, 1984). In another study, a partially
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purified fucosyltransferase from submaxillary glands of secretors showed distinct
preference for the Type 1 precursor chain. This preference was not found for
the weak enzymatic activity found in submaxillary glands from non-secretors
(Betteridge and Watkins, 1985). This "two structural gene" model explains the
existence of the para-Bombay phenotype where the H determinant is found in
secretions but not on erythrocytes. In para-Bombay individuals, the Se gene
is expressed and H is present in body fluids, but both alleles in the H locus
are silent (hh), therefore H is absent from tissues of ectodermal origin (includ¬
ing red blood cells). In Bombay individuals both genes are inactive and the H
determinants are not found on cells or in secretions (Oriol et al., 1986).
The Se and H genes are closely linked on the short arm of chromosome 19
(Oriol et al., 1981); and it has been suggested that one of the genes might have
been derived by gene duplication in the course of evolution (Le Pendu et al.,
1985).
1.1.3 The Lewis system
Biochemistry
Lewis antigens on red blood cell surfaces differ from the ABH antigens in that
they are not synthesized endogenously by the erythrocytes but passively ac¬
quired from the plasma (Sneath and Sneath, 1955; Marcus and Cass, 1969).
The site of production of the Lewis antigens which circulate in the plasma is
unknown. It is also not known if there are specific receptors on the cells for
glycolipids carrying the Lewis determinants or if they are non-specifically ad¬
sorbed into the lipid bilayer of the cells membrane. The Lewis gene product is
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an a-4/3-L-fucosyltransferase that adds an a-L-fucosyl residue to the 0-4 posi¬
tion of the subterminal N-acetylglucosamine of the H or precursor Type 1 chain
(Figure 1.5). The type of acceptor molecule, H Type 1 or precursor Type 1,
determines the type of Lewis determinant formed, Lewis4 (Le4) or Lewis" (Lea),
respectively. Lewis1 and Lewis" are isomers of Le° and Le4 respectively, formed
on Type 2 structures by the action of a a-3-L-fucosyltransferase. The gene that
codes for this enzyme is situated at a site distinct from the Lewis locus.
In saliva and other secretions, Le° and Le4 determinants are carried on the
same types of glycoprotein molecules as the ABH determinants (Watkins, 1974).
In 1948, Grubb reported that individuals whose red blood cells typed as
Le° positive and who had only Le" in their secretions did not express the ABH
determinants in their secretions (non-secretors). In contrast, individuals whose
red blood cells typed as Le4 positive were secretors of ABH determinants and
in addition expressed Le" and Le4 in their body fluids. Now it is known that
red blood cells of secretors express some Le", but its quantity is insufficient for
detection by haemagglutination using anti-Lea antibodies. Individuals who do
not express any Lewis determinants on their red blood cells (Lewis negative)
could be either secretors or non-secretors; and their saliva does not contain Le°
or Le4. It should be stressed that the presence of Lewis antigens in secretions
and on cell surfaces depends on the expression of the Lewis gene and not on the
secretor gene.
Genetic control and interaction with the Se, H and ABO genes
The blood group determinants present on cell surfaces and in secretions are the





Lewis b antigen Lewis a antigen
Figure 1.5: The pathway of production of H, B, A and Lewis determinants
in secretions. Symbols as in Figures 1.1 and 1.2. The arrows represent the
reactions possible in individuals possessing the genes indicated by the letters.
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are involved in regulating the expression of the blood group determinants. The
first is the glycosyltransferases found within an individual. These depend on the
alleles inherited at the blood group loci and the transcription and translation
of these genes. The sequence of glycosylation is another factor which influences
the blood group repertoire. The action of one enzyme on a precursor chain can
result in either production of the acceptor for another enzyme or changing the
structure to make it unsuitable as an acceptor for another glycosyltransferase.
Since enzymes coded by different genes can compete for the same acceptor, the
amount of enzyme and its kinetic properties are important factors influencing
the type of determinants produced.
The construction of A and B determinants as part of the cell membrane de¬
pends on the action of a fucosyltransferase on Type 2 precursor chains. H Type
2 is the acceptor for the A and B immunodominant monosaccharides; therefore,
if H Type 2 is not formed, as in individuals with the Bombay or para-Bombay
phenotypes, the A and B determinants cannot be expressed. Once H Type 2
is formed, further glycosylation of this structure is determined by the genes ex¬
pressed at the ABO locus. Individuals possessing the A or B alleles, will convert
the H determinant to A or B respectively. If both A and B genes are present,
the enzymes coded by these genes will compete for the same acceptor substance
(H Type 2); and cells of these individuals (AB phenotype) will possess some
molecules carrying the A determinant and some carrying the B determinant.
Recently it has been observed that although each blood group antigen carries
an average of 2 or 4 determinants, the A and B determinant are not found on
the same carrier molecule (Viitala et al., 1986). The rate of expression of each
one of these determinants depends on the relative efficiency and quantity of the
enzymes involved. The O allele does not give rise to a functional product; there¬
fore, individuals inheriting two O alleles will express unmodified H Type 2 on
15
their cell membranes (O phenotype).
In secretions the Type 1 chain is the acceptor substance for the production
of blood group determinants. Two fucosyltransferases coded at different genetic
loci (Se and Le) may compete for this structure. When both Se and Le enzymes
are expressed, the Type 1 precursor chain is first fucosylated by the Se enzyme
to produce H Type 1 determinants. This structure can be further fucosylated by
the Le enzyme to form Le6 determinant. If the precursor structure is first uti¬
lized by the Le enzyme, the structure formed (the Lea determinant) is unsuitable
as a substrate for the Se enzyme. As a result, both Le6 and Le° are formed in
secretors; the relative amounts found depends on the relative activity and level
of the Se and Le enzymes (Watkins et al., 1988). The A and B enzymes also
compete with the Le enzyme for the same substrate. Once a determinant has
been converted to Le4, it cannot function as a substrate for the A and B trans¬
ferases. On the other hand, A and B determinants can be further fucosylated
by the Le enzyme to form ALe4 or BLe4 determinants.
In non-secretors, since the fucosyltransferase coded by the Se gene is not
produced, the only determinant formed is Lea, providing the Le gene is active.
In the rare individuals in whom neither Se nor Le axe present, secretions will
contain unconverted precursor Type 1.
The genes involved in the expression of the blood group determinants in
secretions and on cells and the pathways leading to the production of these
determinants are summarised in Figures 1.4 and 1.5.
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1.2 Blood Group Antigens and Disease Suscep¬
tibility
1.2.1 Introduction
The blood group antigens are a genetically determined characteristic of an indi¬
vidual's cells. The frequency of the genes coding for the enzymes that produce
blood group antigens differ between populations. These differences could arise
through two mechanisms; genetic drift and natural selection. Genetic drift can
be demonstrated by the "founder effect": when a small group of people migrate
to an isolated place and proliferate. If the small group differs from the original
population with respect to certain blood group gene frequencies, this will result
in differences in the frequencies of these genes in the isolated population com¬
pared with their population of origin. Natural selection will influence the gene
frequencies if there are differences in the fitness of the various blood groups.
Most workers now agree that both forces are taking part in establishing the
distribution of blood types in the world (Mourant et al., 1978). Since infectious
diseases are involved in the second factor, this will be discussed in more detail.
The selection against a blood group is determined by the environment and
should result in early mortality or lower fertility of individuals carrying this
blood type. If in a particular environment certain diseases are more common
or tend to be more severe in people of a certain blood type, the frequency of
this blood type should be lower in comparison to other populations where such
condition does not exist. An example is the influence of the malaria parasite on
the distribution of the Duffy blood group antigen in Africa. This example will
be described in the following sections. The forces of natural selection in the case
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of bacterial infections had more influence prior to the advent of antibiotics and
the use of modern therapy when such infections resulted in high infant mortality.
The first attempt to study an association between blood group antigens
and disease susceptibility was performed by Buchanan and Higley (1921) af¬
ter the variation in blood-group frequencies between populations was reported
(Hirszfeld and Hirszfeld, 1919). In their study, Buchanan and Higly determined
the ABO blood groups of 2446 patients suffering from various diseases. They
found no relationship between blood group and disease, probably because the
numbers tested for each disease were too small to yield statistically significant
results. Since then, many statistical studies have been done comparing the
frequencies of the different blood group systems in people suffering from a par¬
ticular disease or infection with the frequencies found in the normal population.
The association between the ABO blood groups and infectious diseases identi¬
fied by statistical surveys were reviewed by Blackwell (1989b). An association
between diseases and secretion of blood group antigens has also been found in
epidemiological studies. Individuals who do not secrete the ABH blood group
antigens into their body fluids (non-secretors) were found to be more susceptible
to a wide range of diseases compared to secretors of blood group antigens. This
thesis is concerned with this association which will be described in section 1.2.3.
Some of the strongest associations between diseases and blood groups have
been reported for conditions other than infections: cancer, thrombosis and au¬
toimmune disease (see Mourant tt al., 1978). These are beyond the scope of
this thesis and will not be included, apart from certain autoimmune diseases for
which infectious triggers have been suggested and for which an association with
non-secretion of blood group antigens has been observed.
Two main hypotheses have been proposed to explain the differential suscep-
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tibility of individuals of a particular blood type to an infectious agent. The first
is based on the experiments that have shown that antibodies against ABH anti¬
gens cross-react with certain Gram-negative bacteria (Springer et al., 1961). It
has been suggested that such cross-reaction could promote rapid phagocytosis in
individuals with antibody to that particular blood group antigen (Eichner et al.,
1963). These "natural antibodies" might protect individuals from disease when
exposed to bacteria expressing the cross-reactive antigen. The second hypothesis
is based on experiments that demonstrated the binding of some microorganisms
to particular blood group determinants. It has been suggested that blood group
structures on the host cell can serve as a binding site for microorganisms, thereby
increasing susceptibility of individuals possessing these structures to infections.
Other immune defence mechanisms have been suggested to contribute to the
increased susceptibility of non-secretors to infections. These will be described
later in this introduction. This thesis examines differential susceptibility of non-
secretors to Neisseria meningitidis in terms of blood group antigens as receptors
to bacteria.
1.2.2 The Duffy blood group antigen, susceptibility to
malaria and natural selection
The importance of infectious diseases in natural selection was first recognized
by Wells in 1818 who suggested that the genetic distribution of the populations
in Africa had been influenced by resistance to local diseases (see Barnwell et
al., 1989). To date, the only disease that has been demonstrated to influence
population genetics is malaria.
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The frequencies of two distinct genes, both related to red blood cells, have
been associated with susceptibility to malaria: the gene coding for haemoglobin
S and that which codes for the Duffy antigen. Two alleles control the expres¬
sion of haemoglobin. In most parts of the world haemoglobin A is the normal
type found. In some areas, especially in Africa, haemoglobin A is partially
replaced by haemoglobin S. Heterozygous individuals expressing one allele for
normal haemoglobin (A) and one of the rare allele (5), will have a mixture of
both types of haemoglobin; these individuals axe healthy. In contrast, individ¬
uals homozygous for the S gene will have sickle-cell anaemia and usually die
in infancy. Although the S gene is lethal, it is present in Africa at a high and
stable frequency compared with other parts of the world. The reason for that is
probably the fact that individuals heterozygous for haemoglobin (AS) are more
resistant to malaria caused by Plasmodium falciparum than normal individuals
(AA) (for a review see Mourant, 1983). Cells carrying the S gene have a me¬
chanical distortion that by unknown mechanisms leads to the destruction of the
parasite.
The association between the expression of the Duffy blood group antigen
and malaria is the only case where the distribution of blood type shows a strong
association to the presence of an infectious agent. For many years it has been
known that the distribution of the two major phenotypes of the Duffy antigens
Fya and Fy6, vary dramatically between white and black populations. In white
populations almost all individuals are positive for one or two of the Duffy alleles.
In contrast, the majority of Negroes in and outside Africa are negative for the
two types of Duffy antigen (Sanger et al., 1955).
It is known that African and American Blacks are resistant to malaria in¬
fection due to Plasmodium vivax which is highly infective to other raxes. Miller
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et al. (1975) were the first to report an association between the Duffy blood
type and susceptibility to P. vivax. Direct studies on P. vivax could not be per¬
formed, since the parasites were difficult to obtain and could not be cultured.
Instead, Plasmodium knowlesi, which in vivo invades rhesus monkey erythro¬
cytes and is closely related to P. vivax, was used to study the invasion of human
red blood cells of different Duffy types. In these experiments, it was found
that invasion rates of three Duffy phenotypes (Fya+4~, Fya-6+ and Fya+i>+) were
similar, but almost no invasion was observed for Duffy negative erythrocytes
(Fy°-4-). They also reported that once cells were treated with proteolytic en¬
zymes which destroy the Duffy determinant, the cells were resistant to invasion.
Malaria merozoites can attach to both Duffy negative and Duffy positive cells,
but the invasion process is only possible in Duffy positive cells. On the basis
of these observations, they have speculated that at least two receptors are used
for attachment of merozoites to red blood cells; the Duffy determinant being
the receptor for the internalization phase. This report became more relevant
to human malaria when 11 black and 5 white volunteers were experimentally
exposed to bites of mosquitos infected with P. vivax (Miller et al., 1976). In
this study, they found that only the Duffy negatives (5 blacks) were resistant to
erythrocyte infection. Only recently, a direct in vitro study has been preformed
which confirmed previous studies and showed that a Duffy determinant, Fy6, is
a receptor for P. vivax merozoites (Barnwell et al., 1989). This structure was
reported to be expressed in all human red cells except Fya_i~ (Nichols et al.,
1987). The Fy6 determinant was found to be the receptor for two species of
malaria: P. vivax and P. knowlesi. Barnwell et al. (1989) also showed that
Plasmodium falciparum merozoites use a different receptor not related to the
Fy6 determinant.
Although P. vivax infection rarely causes death in Western populations, it
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may decrease survival in African children who are malnourished or who have
other endemic diseases (Miller et al., 1976). Since erythrocytes are the site
of reproduction of malaria parasites, it is expected that genes which increase
resistance of red blood cells to invasion by the parasite will occur in higher
frequency in areas hyperendemic for malaria.
In his book 'Blood Relations', Mourant (1983) suggests a two stage evolu¬
tionary process, which selects for the distribution of the genes A, S and Duffy,
and the type of malaria found in Africa. At first, P. vivax was endemic in Africa
as it still is in other parts of the world. A mutation in the Duffy locus gave rise
to a new gene which does not code for the two common types of Duffy deter¬
minants, Fya and Fy6. This gene spread in the population and gave rise to a
few homozygotes who were completely resistant to malaria and, therefore, had
a selective advantage. As a result of natural selection, the gene spread until the
majority of the population did not express the Duffy antigen used as a recep¬
tor for invasion by P. vivax (probably Fy6 as recently reported). It is possible
that for some time Africa was almost free of malaria until P. vivax underwent
a mutation which converted it into a form that could invade Duffy negative red
blood cells. This mutation created a new species, P. falciparum, which replaced
P. vivax in Africa, also as a result of natural selection.
The mutation of the malaria parasite created a much more virulent dis¬
ease agent than the original parasite and led to a second genetic change in the
African population. This time a new type of haemoglobin evolved, haemoglobin
S, which provided complete resistance to P. falciparum. This mutation could
not completely replace the original type of haemoglobin (haemoglobin A), since
individuals who are homozygous for this allele die at a young age. In the het-
erozygotes, it provides resistant to malaria and almost no other effects.
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The evolutionary process described can explain the high frequency of Duffy
negative erythrocytes and haemoglobin S in Negroes; and the existence of P.
falciparum as the main type of malaria causing agent in tropical Africa.
1.2.3 Secretor status and disease susceptibility
Several epidemiological studies have reported an association between the ability
to secrete blood group antigens into body fluids and various diseases. In these
studies, individuals in patient populations suffering from a specific disease were
defined as secretors or non-secretors on the basis of the presence of the ABH
antigens in their saliva. The proportions of secretors and non-secretors of the
patient group were compared to those of a control population. In the studies
that have shown an association, non-secretors of the ABH determinants were
found to be more susceptible to the disease. The diseases that have shown
an association with secretor status can be divided into two groups; infectious
diseases (Table 1.1) and autoimmune diseases (Table 1.2). A number of different
bacterial and fungal infections of mucosal surfaces have been associated with
non-secretion. The increased susceptibility of non-secretors to infection due to
Neisseria meningitidis is the topic of this thesis and it will be described in detail
in the next section. Among autoimmune diseases, only conditions that have
a proposed infectious trigger were found to be associated with secretor status
(see Table 1.2). From these observations, it was suggested that the increased
susceptibility of non-secretors to autoimmune diseases is secondary to their being
more susceptible to the infectious agent that triggers the autoimmune condition.
An example of this is the higher proportion of non-secretors among patients
with rheumatic fever and rheumatic heart disease (reviewed by Haverkorn and
Goslings, 1969). These conditions are known to occur following streptococcal
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Table 1.1: Infections associated with non-secretion of blood group antigens
Infectious agent Reference
Urinary tract
E. coli Kinane et al., 1982
Blackwell et al., 1987b
Gastointestinal tract
V. cholerae Chaudhuri and Das Adhikary, 1978
Genital tract







Haverkorn and Goslings, 1969
Blackwell et al., 1986a
Blackwell et al., 1990
Blackwell et al., 1986a





Thom et al., 1989
Burford-Mason et al., 1988
Arneberg et al., 1976
Holbrook and Blackwell, 1989
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Table 1.2: Autoimmune diseases associated with non-secretion of blood group antigens and
the microorganisms that have been proposed to trigger the disease














































Weiss et al., 1983
Heyma et al.,1986
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infections where more non-secretors are found among the patients and among
carriers of the bacteria than in the control population (Haverkorn and Goslings,
1968).
Recently, secretors have been found to be more susceptible to several viral
infections (M. Raza, personal communication) . This study is the first to suggest
an association between secretor status and viral infection and it is the first
condition in which secretors are over-represented.
The secretion of the A, B, H antigens into saliva and other body fluids,
is controlled by the Secretor gene which is inherited in a Mendelian dominant
fashion. While 25% of the population are expected to be homozygous for the
recessive gene (non-secretors phenotype), the proportion of non-secretors varies
in different parts of the world. As mentioned before, the forces that are thought
to play a role in determining the gene frequencies of a blood group system
are genetic drift and natural selection. The selective pressures on the Se gene
are not clear. The epidemiological data suggests selection against the non-
secretor phenotype, since non-secretors are more susceptible to bacterial and
fungal infections. On the other hand, a selection against the secretor gene was
proposed for haemolytic disease of the newborn due to ABO incompatibility (for
a review see Mourant, 1982). It was suggested that infants with the secretor
phenotype are more susceptible to this condition; however, the role of secretor
status of the infant in the pathogenesis of this condition has not been conclusively
determined. The frequency of the Se gene in many parts of the world is as
expected by its mode of inheritance. The variation in the frequencies of this gene
in isolated populations is more likely to be due to founder effect than natural
selection (Eriksson et al., 1986). Examples of variations in Se gene frequency
are shown in a study done in northern populations (Eriksson et al., 1986). In
26
this study Icelanders were found to have one of the highest proportion of non-
secretors (up to 35.94%); and the frequency of non-secretors among Finnish
Lapp populations was found to be the lowest reported in Europeans (2.2%).
Variations in the Se gene frequency are also seen between communities in the
same country; for example the proportion of non-secretors in Plymouth and
Stonehouse compared to blood donors in South-west England (Phipps and Perry,
1989; Blackwell and Weir, 1990) (see Table 1.3). These variations emphasize the
importance of testing the proportion of secretors and non-secretors in the local
population, when performing an epidemiological study.
1.2.4 Secretor status and susceptibility to meningococci
The association between the expression of the secretor gene and infection by
Neisseria meningitidis was reported in several studies. Three studies in dif¬
ferent parts of the world have found higher proportions of non-secretors among
patients with meningococcal disease compared to the proportion of non-secretors
in the local population (Blackwell et al., 1988). The results observed in these
studies also demonstrate variations in the proportion of non-secretors in differ¬
ent populations and hence the need for a local control population (Table 1.4).
In 1986, a large scale community survey was undertaken in the town of Stone-
house, Gloucestershire, during an outbreak of meningococcal disease (Blackwell
et al., 1989b). This survey has shown a higher proportion of non-secretors
among patients with meningococcal disease compared with their proportion in
the local control population (see Table 1.4). In addition, in this study the pro¬
portion of non-secretors in Stonehouse was found to be significantly higher than
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South-west England 23.4 <0.005
Study 3:
Plymouth 37.4
South-west England 23.4 <0.0005
P values were obtained by comparing the proportion of non-secretors in
the outbreak town with the proportion in its surrounding area.
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Table 1.4: Proportion of non-secretors among patients with invasive
infection due to N. meningitidis and local control
Total Non-secretors(%) P-value
Scotland


























P values were obtained by comparing the proportion of non-secretors
among patients with the proportion of non-secretors among local control
population.
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the proportion of non-secretors among blood donors in the South-west region
of England (see Table 1.3). These studies indicate that non-secretors are at a
greater risk for meningococcal disease and suggest that prolonged outbreaks of
meningococcal disease appear in areas with a high proportion of non-secretors.
In a subsequent study, the proportion of non-secretors was examined at Air-
drie Academy, Lanarkshire, where a short localized outbreak of meningococcal
disease occurred (Blackwell et a/., 1990). Pattern similar to that found previ¬
ously was observed. The proportion of non-secretors among pupils and staff in
Airdrie was found to be significantly higher than the proportion of non-secretors
among blood donors in Edinburgh and Glasgow (See Table 1.3). In addition,
a higher proportion of non-secretors was found among carriers of N. meningi¬
tidis (47%) compared with the control population (32%) (Blackwell et al., 1990).
These results support the hypothesis that one of the factors contributing to the
susceptibility of non-secretors to meningococcal disease is their increased risk
for carriage of the bacteria. The interactions between the host and the bacteria
underlying these observations are not understood. Knowledge of meningococcal
pathogenesis and factors influencing susceptibility of an individual or population
to this disease are important in development of means to prevent meningococ¬
cal infections. As described in the next section, methods for the prevention of
meningococcal disease are limited at present.
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1.3 Meningococcal infection: biology and pre¬
vention
In the United Kingdom at least one child in every 1000 develops acute bacterial
meningitis by the age of 10. In developing countries, the incidence of bacterial
meningitis is probably higher than that recorded in the industrialized West. In
areas of Africa, where meningococcal disease occurs frequently, acute bacterial
meningitis in childhood may reach a figure as high as 1:100.
Most cases of invasive meningococcal disease are due to encapsulated strains
of the bacterium. Isolates of N. meningitidis can be serogrouped on the basis of
the antigenic structure of their capsular polysaccharides. These serogroups can
be further divided into serotypes on the basis of their outer membrane proteins.
Eight main serogroups of meningococci are recognized (A, B, C, X, Y, Z, 29e
and W135). Most clinical infections are caused by meningococci belonging to
serogroups A, B, or C.
Meningococcal infection is endemic in most Western industrialized countries,
where only modest variations in incidence of meningococcal disease are observed
from year to year. In these parts of the world, geographical clustering of cases
is frequently seen. In epidemics, N. meningitidis strains belonging to group B
or C account for most cases of disease. Acute bacterial meningitis can occur
at any age in previously healthy individuals; however, the disease is seen most
frequently in young children and the age distribution may vary depending on the
strain and the population effected. Household clustering of cases of meningo¬
coccal disease is frequent, especially during epidemics (Greenwood et ai, 1979).
The risk of infection is up to 1:30 in siblings who sleep in the same room as
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patients.
The bacterium is spread mainly by respiratory droplets and transmission is
enhanced by overcrowding. Once inhaled, the bacteria may establish themselves
in the upper respiratory tract; and, in most individuals, infection is restricted
to this site. The prevalence of colonization in non-epidemic periods is between
5 and 10% (Greenfield et al., 1971).
Meningitis can follow spread of bacteria from the respiratory tract through
the blood. Unless the skull has been fractured, direct spread from the nasophar¬
ynx to the meninges is rare. If septicaemia occurs, it usually does so within a
short period after colonization. Infection of the meninges can be prevented at
two stages: at colonization or after invasion of the blood. At the colonization
stage, mucosal defence mechanisms such as secretory IgA might play an im¬
portant role. In the blood, bactericidal substances provide a second protective
barrier which must be overcome before the brain is reached. Serum bactericidal
substances include specific antibodies against the capsular polysaccharides and
membrane proteins. Their importance in preventing meningitis is demonstrated
by the correlation found between resistance to disease and high levels of serum
antibodies to the bacteria. Formation of specific serum antibodies can follow
asymptomatic nasopharyngeal carriage or infection with harmless commensal
bacteria that share antigenic determinants with the pathogen. Thus carriage of
harmless bacteria such as N. lactamica can induce protective antibodies against
meningococci. On the other hand, infection with cross-reactive organisms may
induce IgA antibodies that have been reported to block bactericidal activity of
IgG and IgM (Griffiss, 1975).
Because nasopharyngeal carriage is much more frequent than meningococcal
disease, carriers rather than patients are the usual source of new meningococcal
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infection. The ratio of carriage to cases varies from 100:1 during an epidemic
to 1000:1 during non-epidemic periods. As carriage may persist for months,
carriers can act as a persistent source of infection. Possible ways of decreasing
the spread of meningococcal meningitis include treatment of susceptible hosts
or reduction of the pool of infection by reducing carriage rate. The two main
approaches are chemoprophylaxis and immunization.
Sulphonamides were effectively used for over 20 years to eradicate meningo¬
coccal carriage and disease in military recruits. In 1963, an outbreak of meningo¬
coccal meningitis due to group B sulphadiazine resistant meningococci occurred
in San Diego (Millar et al., 1963). Since then, an increased proportion of
sulphonamide resistant strains have been reported. The recent epidemics in
Stonehouse and Airdrie were due to sulphonamide-resistant strains (Cartwright
et al., 1987; Blackwell et al., 1990). In the search for other antimicrobial agents,
penicillin G, erythromycin, oxytetracycline and ampicillin were found to be in¬
effective in reducing colonization by the sulphonamide-resistant strains (Dowd
et al., 1966). Later, rifampicin was found to be efficient in reducing carriage,
but studies have shown that resistance developed rapidly among staphylococci,
enteric bacteria and meningococci (for review see Broome, 1986). At present,
minocyclin is widely used for prophylaxis and is recommended for use for house¬
hold contacts of patients with meningococcal meningitis. The development of
minocyclin resistance has not been a problem and a very low proportion of
resistant strains (0.15%) has been reported (Band et al., 1983).
Another method used for prevention of meningococcal disease is vaccination
with meningococcal polysaccharides (group A, C, Y and W135). The efficacy of
these vaccines for reducing carriage is questionable. Initially, the use of group
C polysaccharide was found to reduce carriage rate by 30-50% (Gotschilch et
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al., 1969). More recently, a vaccination trial in Africa showed that the use
of group A polysaccharide had no effect on the carriage rate (Blakebrough et
al., 1983). Vaccination with these polysaccharides is used mainly for military
personnel. Group C vaccine is not effective in children under the age of 2 years
and a vaccine against group B strains is not available. Since serogroups B
and C meningococci are the main causes of meningitis and one of the most
susceptible populations are young children, vaccination of civilians is not feasible.
Many studies are now directed at developing meningococcal vaccines that will
be safe, inexpensive, easily administered, immunogenic in infants and provide
prolonged immunity (for review see Griffiss et al., 1987). Determination of the
host parasite interactions that enhance susceptibility of individuals to the disease
might facilitate this goal and identify the population that should be immunized.
1.4 Hypotheses proposed for the association be¬
tween secretor status and disease
1.4.1 Secretor status and immunoglobulin level
An association between the level of immunoglobulins and secretor status has
been studied in an attempt to explain the increased susceptibility of non-secretors
to infections. The first report of differences in antibody levels between secretors
and non-secretors was an increased level of isoantibody in secretors compared
with non-secretors (see Grundbacher and Shreffler, 1970). In a subsequent study,
Grundbacher and Shreffler (1970) confirmed this observation by demonstrating
higher levels of anti-B in secretors compared with non-secretors. Secretors were
found to have a significantly higher level of total serum IgG compared with
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non-secretors. This higher total IgG level has been suggested to account for
the increase in isoantibody level. Similar results, where secretors were found to
possess higher levels of immunoglobulins, have been reported for total salivary
IgA (Waissbluth and Langman, 1971) and serum IgA (Grundbacher, 1972). An¬
other study reported higher levels, though not statistically significant, of serum
IgG and IgM in secretors compared with non-secretors (Waissbluth and Lang-
man, 1971). As suggested by the authors, the differences were probably not
statistically significant because of the small numbers tested .
The lower immunoglobulin levels found in non-secretors compared with se¬
cretors were used to explain the increased susceptibility of non-secretors to
rheumatic fever and rheumatic heart disease (Glynn et al., 1956; Clarke et al.,
1960). These two conditions follow a streptococcal infection which has been
shown to be associated with non-secretion of blood group antigens. The initial
infection could be influenced by the ability of an individual to generate an im¬
mune response to the bacteria. Therefore, lower level of immunoglobulins found
in non-secretors compared with secretors might result in increased susceptibil¬
ity to streptococcal infection. This increased infection rate will predispose the
non-secretors to rheumatic fever and rheumatic heart disease.
In a later study on the association between secretor status and immunoglob¬
ulin levels, total serum IgA and IgG were compared by a quantitative radial
immunodiffusion assay in women with recurrent urinary tract infections (UTI)
(Blackwell et al., 1987b). The women in this study were divided into two groups
according to the length of time they had suffered from these infections. In both
groups, newly referred and long term sufferers, there was an increased propor¬
tion of non-secretors among the patients compared with local controls. In the
group of patients recently referred to the clinic, no difference was observed in the
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amounts of serum IgA or IgG between secretors and non-secretors. In contrast,
among patients monitored by the clinic for the last 20 years, non-secretors were
found to have higher levels of total serum IgA and IgG.
In this report, unlike previous studies, the patients suffered from recurrent
infections. Repeated episodes of a particular infection will result in increased
levels of immunoglobulins specific for the pathogen. If the increase in specific im¬
munoglobulin (not measured in this study) is reflected in the total immunoglobu¬
lin level, then higher levels of total antibodies might simply reflect an increased
number of episodes. This possibility is supported by the higher level of im¬
munoglobulins found in the patients suffering from recurrent UTI for the last 20
years, compared with patients recently referred to the clinic (Blackwell et al.,
1987b).
It is possible that the lower immunoglobulin levels in healthy non-secretors
compared with secretors reported in earlier studies, predisposes non-secretors
to initial infections. In this case, non-secretors will suffer from more episodes
of colonization than secretors since their immunoglobulin levels in the healthy
state are lower than secretors. Repeated episodes of infection will result in high
levels of immunoglobulins, as reported for women suffering infections for many
years (Blackwell et al., 1987b). Non-secretors who suffered from infections for
a shorter period show the same immunoglobulin levels as secretors, since the
higher immunoglobulin levels reported for healthy secretors is balanced by the
increased episodes of colonization in non-secretors. The high level of antibodies
in non-secretors became apparent only after a long period of recurrent infections.
A later study comparing total salivary IgA levels in secretors and non-
secretors among carriers of N. meningitidis and in non-carriers (Blackwell et
al., 1989a) supports this hypothesis. In this study, among carriers of the bac-
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teria, no difference was found in total salivary IgA levels between secretors and
non-secretors. However, carriers of the bacteria had higher levels of salivary
IgA than non-carriers. This suggests two explanations: the specific response
is reflected in the total immunoglobulin levels; or, bacterial components cause
polyclonal B cell activation. In contrast, among non-carriers a higher level of
serum IgA was found in secretors compared with non-secretors.
The class of antibody produced, not just the quantity of antibodies, is an
important factor in protecting against infections. As suggested by Blackwell et
al. (1989b) high levels of IgA, specific for the capsular polysaccharide in serum of
non-secretors, might compete with complement fixing isotypes (IgG and IgM)
for binding sites on the surface of the pathogen. The ability of IgA to block
bactericidal activity of meningococcal antisera has been demonstrated (Griffiss,
1975).
Conflicting results have been reported for the differences in immunoglob¬
ulin levels between secretors and non-secretors. No difference in total serum
or salivary concentration of IgA between secretors and non-secretors was re¬
ported among patients with spondyloarthropathies (Shinebaum et al., 1987).
This study reported a higher proportion of non-secretors among these patients
which does not seem to be the result of a deficiency or overproduction of IgA.
The importance of any difference in immunoglobulin level in the increased
susceptibility of non-secretors to infections is not clear. It has been suggested
that the concentrations of immunoglobulins differ between secretors and non-
secretors depending on their state of health and infection. The level of im¬
munoglobulins and their isotype might play an important role in the increased
susceptibility of non-secretors to infections, or conditions triggered by infec¬
tions. Further investigations of the specific immune response of secretors and
non-secretors to pathogens and its effect on the total immunoglobulins levels are
required.
1.4.2 Complement levels and secretor status
The gene that codes for the third component of the complement system (CS)
is located on chromosome 19 and was found to be closely linked to the secretor
gene (Elberg et al., 1983). Since complement is an important component of the
immune system, C3 has been proposed as a factor which might play a role in
the association between secretor status and disease.
The third component of complement occupies a critical position in the acti¬
vation of the complement system. Many of the biological functions of this system
are elaborated with the activation of C3. Activation of C3 by the classical or
alternative pathways results in generation of an anaphylatoxin that stimulates
an inflammatory response. The larger fragment (C3b) can bind to cell surfaces
such as bacteria and activate the cascade from C5 to C9 resulting in cell lysis.
The binding of C3b to a particle also acts as an opsonin mediating phagocytosis;
immune complexes are bound by macrophages, monocytes, polymorphonuclear
leucocytes and B lymphocytes by means of receptors specific to C3b and its
breakdown products.
Complement levels have been suggested to play a role in the association
found between non-secretors and some disease conditions (Blackwell 1989b). In
the Stonehouse study C3c levels among non-carriers of N. meningitidis were de¬
termined by quantitative radial immunodiffusion. The level of C3c was found
to be slightly lower in non-secretors compared with secretors. In 8 non-carrier
individuals, C3c levels were found to be below the normal range; 7 of these were
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non-secretors (Blackwell, 1989b). Among patients with diabetes, lower levels of
C3c were found in patients with insulin dependent diabetes mellitus (IDDM)
but not among those with non-insulin dependent diabetes mellitus (NIDDM)
(Charlesworth et al., 1987). Non-secretors of blood group antigens were found to
be over-represented among patients with IDDM but not among NIDDM (Black-
well et al., 1987a). These two observations triggered a third study on patients
with IDDM, in which lower levels of C3c were found among non-secretors com¬
pared with secretors (Blackwell et al., 1988). Development of IDDM is not
linked only to genetic factors, environmental factors such as infectious agents
have been suggested to play a role in the aetiology of the disease (see Table 1.2).
It is possible that C3 levels could influence the occurrence of the infectious state
which might predispose certain individuals to develop IDDM. The association
between secretor state and C3 levels is not well established and the biological
significance of differences in complement levels are not known.
A factor which was not considered in the association between secretor sta¬
tus and C3 is the possible association with the two main variants of C3. The
third complement component exhibits genetic polymorphism (reviewed by Al-
per, 1986). The genetic variants of the protein are inherited as an autosomal
codominant trait. Several variants have been found and characterized by agarose
gel electrophoresis; but only two, C3S (slow) and C3F (fast) occur frequently.
In most populations the sum of the gene frequencies of CSS and CSF are 99%,
where the gene frequency of CSS ranges between 77-99% (Raum et al., 1980).
The biological significance of the C3 polymorphism is still unknown. No dif¬
ference between the two variants have been found with regard to immunochem-
ically measured quantities, the stability, the molecular size or the haemolytic
capacity of sera of different C3 phenotypes (reviewed by Bronnestam, 1973).
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Cytolysis is only one of the activities of C3. This molecule is also involved
in immune adherence and promotion of phagocytosis. In only one study has
a difference between the two variants regarding these functions been reported
(Arvilommi, 1974). In this study, C3F was found to have an enhanced capacity
to bind to complement receptors on human mononuclear cells.
Several studies have reported a significant increase of the CSF allele among
patients with various diseases (Bronnestam, 1973; Elmgreen et al., 1984; Jans
and Sorensen, 1980; Regueiro and Arnaiz-Villena, 1984; Schiotz et al., 1978;
Srivastava and Srivastava, 1985; ). A relationship was also found between C3
polymorphism and antibody titre (Bronnestam and Cedergren, 1973). In this
study, C3S was associated with high titres of immune antibodies to A and B
blood group antigens in mothers with ABO incompatible infants. The mecha¬
nism behind this observation is not known but it was suggested that C3 variants
might influence antibody production (Bronnestam and Cedergren, 1973). Al¬
though functional differences between the two variants are not fully understood,
such differences might contribute to the increased susceptibility of patients who
inherited the CSF gene. Since the Se and the CS genes are linked, it is possi¬
ble that the inheritance of se along with the CSF allele could account for the
increased susceptibility of non-secretors to diseases.
1.4.3 Blood group antigens as receptors for microorgan¬
isms
Blood group antigens are found on the surface of many tissues, including the
surface of epithelial cells which are often the site of colonization for microorgan¬
isms. The serologically defined carbohydrate structures that form the blood
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group determinants are present as a constituent of various macromolecules.
Many macromolecules in secretions are glycosylated and the expression of cer¬
tain blood group determinants in this situation will be under the control of the
secretor gene. Some of the blood group antigen structures found on the surface
of cells are not made endogenously; they are adsorbed from secretions onto the
cell surface. Hence, the secretor gene influences the distribution and presence of
some carbohydrate structures on the surface of epithelial cells and in secretions.
The cell surface is abundant in carbohydrate molecules; and, carbohydrate
structures have been postulated to be one of the most probable attachment site
for microorganisms (Lark, 1986). The role of carbohydrate structures in specific
attachment of viruses and bacteria to cells has been extensively studied. The
work of Burnet et al. in the 1940's described an enzyme activity, "receptor
destroying enzyme", responsible for specific inhibition of influenza virus binding
to the cell surface (See Burnet and Stone, 1947). Later the substance being
split off was identified as N-acetyl-neuraminic acid and at about the same time
it was shown that several bacterial species specifically bind to mannose (for
review see Bock et al., 1988). About 15 years later the iV-acetyl-neuraminic
acid containing glycolipid, the ganglioside GM1, was described as the specific
receptor for cholera toxin. Binding to this cell surface molecule is a crucial event
for the subsequent effects of the toxin (Eidels et al., 1983). Brain gangliosides
in a liposome model have been shown to be the binding site for Sendai virus
(Haywood, 1974).
Blood group antigens are expressed at a very high density on the surface
of the cells. They are widely distributed in the body and show variation in
expression between tissues, individuals and species. If blood group antigens act
as receptors for microorganisms, then tissue tropisms, individual or species sus-
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ceptibility to infection can in part be explained at the receptor level. Although
blood group antigens are a potential binding site for microorganisms, there is
very little evidence for such a role. The Duffy antigen is known to be the receptor
for Plasmodium knowlesi (Miller et al., 1975). In 1980, two independent groups
(Kallenius et al., 1980; Leffier and Svanborg Eden, 1980) demonstrated specific
binding of E. coli to Galal-4Gal containing molecules. These structures are
part of the P blood group antigen and are found on cells of the urogenital tract
where they play a role in the colonization of E. coli strains expressing P fim¬
bria. The Anton antigen has been reported to be the receptor for Haemophilus
influenzae on oropharyngeal epithelial cells (Van Alphen et al., 1986).
As just described, carbohydrate determinants have been shown to be re¬
ceptors for microorganisms. Differences between secretors and non-secretors
in carbohydrate structures present on the surface of their epithelial cells could
influence their susceptibility to colonization by pathogens.
1.5 Aims of this study
Epidemiological studies indicate that non-secretion of blood group antigens is
associated with increased susceptibility to several infections and autoimmune
conditions. The aim of this study is to examine host-parasite interactions con¬
tributing to the increased susceptibility of non-secretors to meningococcal dis¬
ease and carriage of N. meningitidis.
A number of factors might be involved in the increased susceptibility of
non-secretors. At present, very few differences have been described between
secretors and non-secretors of blood group antigens. Among those that have
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been reported, the only ones that can explain the increased susceptibility of
non-secretors are: immunoglobulin levels, complement levels and blood group
antigen expression. The only factor that is strongly associated with secretor sta¬
tus, is well defined and known to be directly influenced by the secretor gene is
the expression of several blood group antigens. The differences in the expression
of blood group antigens between secretors and non-secretors are summarised in
Table 1.5. On the basis of these differences, two hypotheses have been proposed
to explain the increased susceptibility of non-secretors to infections (Blackwell,
1989a,b). Both suggest blood group determinants might be receptors for ad-
hesins on the surface of microorganisms.
The first suggests that ABH or Lewis6 antigens in the body fluids of secretors
can bind to lectin-like adhesins on the surface of microorganisms and block their
attachment to epithelial cells. In the case of N. meningitidis, disease and carriage
of the bacteria were not associated with specific ABO blood group but with the
ability of the individual to secrete the antigens. This suggests that the A and
B determinants are not involved in the lower prevalence of secretors among
patients with meningococcal disease. The presence of Lewis6 is dependent on
the expression of the secretor gene, and is found only in the secretions and on the
cells of secretors. To suggest this determinant is a receptor that could block the
attachment of the bacteria to secretor's cells implies that the same receptor is an
attachment site on the cell surface. In this case the attachment of the bacteria
to Lewis6 antigen will not explain the increased susceptibility of non-secretors to
carriage and disease since this antigen is not expressed on their cells. Since the
H gene is expressed in almost all people, the H determinant is found on the cells
of most individuals independent of their blood type and secretor status. This
determinant is found only in the secretions of secretors, independent of their
blood type, where its expression is dependent on the presence of the secretor
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Table 1.5: Blood group antigens found in secretors and non-secretors
Antigen Secretors Non-secretors
Cells Secretions Cells Secretions
H (A/B)* + + + -
Lewis3** +/- +/- + +
Lewisb ** + + -
+ Present
Absent
+/- Present in small amounts
* Exact structure depends on the genotype
** Dependent on expression of the Lewis gene
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gene. If the H determinant is one of the receptors for bacterial attachment
on epithelial cells, the presence of this antigen in secretions of secretors might
reduce the density of colonization by interfering with attachment. This model
could explain the lower prevalence of infection and carriage among secretors.
The second hypothesis suggests that the Lewis0 determinant which is found
predominantly in non-secretors is a receptor for bacteria on the surface of cells.
There are two pieces of evidence which suggest that the Lewis0 determinant
is a receptor for bacterial attachment. Lomberg et al. (1986) found that the
binding of uropathogenic strains of E. coli to cells from non-secretors was higher
compared to the binding to cells from secretors, irrespective of their P and ABH
blood groups. They suggested that the addition of A, B or H determinants
under the control of the Se gene to the epithelial glycoconjugates could block
the receptor for the bacteria by modifying the surrounding molecules or the
receptors themselves. Another possibility, which they did not consider, is that
the bacteria bind to the Lewis0 determinant which is the only structure known to
be present on non-secretors' cells in higher amounts than on secretors' cells (see
section 1.1.3). In another study the binding of Candida blastospores to epithelial
cells from secretors and non-secretors was investigated. The attachment of the
blastospores, from one of the two Candida strains tested, to cells from non-
secretors was blocked by anti-Lewis°. Pre-treatment of the epithelial cells with
anti-Le6 did not decrease binding (May et al., 1989). It was concluded that the
Le° determinant on the surface of epithelial cells might be one of the receptors for
binding blastospores of some strains of Candida. This observation might explain
the epidemiological studies which have found an increase in the proportion of
non-secretors among patients and carriers of Candida species (Blackwell et al.,
1989b, Thorn et al., 1989).
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The aim of this study was to investigate the role of blood group antigens
as receptors for N. meningitidis in the context of the two hypotheses suggested
above. Assays were developed to quantitate H and Lea determinants on cells
and/or in secretions and to measure bacterial attachment to epithelial cells. The
ability of the bacteria to bind Lea and H from solution was investigated. Once
the determinant that acts as a receptor on the cell is identified, this can be
used to examine the structure on the bacteria which interacts with the receptor.
Identification and isolation of the bacterial adhesin might be used as an approach
for the development of preventive strategies.
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Chapter 2
General materials and methods
47
2.1 Buffers
All chemicals were analytical grade obtained from BDH Chemicals Ltd. (Poole,
Dorset, UK) or Sigma (Poole, Dorset, UK).
2.1.1 1M Carbonate-bicarbonate buffer (pH 8.9)
Stock solutions of 1M sodium carbonate and 1M sodium bicarbonate were pre¬
pared. The buffers were mixed in the proportion 1:9 (v/v) adjusted to pH 8.9
with one of the stock solutions (carbonate raises pH, bicarbonate lowers pH).
The bicarbonate solution was prepared fresh for each experiment.
2.1.2 Dulbecco's phosphate-buffered saline , solution A
(DPBS)
This buffer was composed of the following: 136 mM sodium chloride; 2.6 mM
potassium chloride; 8.1 mM sodium hydrogen phosphate; 1.47 mM potassium
dihydrogen phosphate; 0.2% aqueous phenol red (pH 7.3).
2.1.3 Dulbecco's phosphate-buffered saline (DPBS+B)
This buffer was prepared by adding 0.9 mM Ca2+ and 0.4 mM Mg2+ ions to
Dulbecco's phosphate-buffered saline.
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2.1.4 Phosphate-buffered saline (PBS) (pH 7.2)
PBS contained 0.01 M phosphate buffer pH 7.2 with 0.15 M NaCl.
2.1.5 Phosphate citrate buffer (PCB) (pH 5)
PCB contained 0.1 M sodium hydrogen phosphate and 0.1 M citric acid, the pH
adjusted to pH 5.
2.2 Subjects
Subjects used in this study were healthy staff and students in the Depart¬
ment of Bacteriology, University of Edinburgh. The ABO blood groups of the
donors were determined from heparinized blood samples by slide agglutination
with monoclonal antibodies (Scottish National Blood Transfusion Service). The
secretor-state of individuals was determined by the haemagglutination inhibition
assay with saliva (Mollison, 1983).
2.3 Collection of epithelial cells
Buccal epithelial cells (BEC) from healthy individuals were collected by rub¬
bing the inside of the cheeks with cotton swabs. Nasopharyngeal cell (NPC)
and oropharyngeal cells (OPC) were collected from one secretor and one non-
secretor with cotton swabs. To remove the cells, swabs were rinsed in 20 ml
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DPBS+B. Cells were washed twice in DPBS+B (300 g for 10 min) and their
concentration adjusted to 2.5x10s cells/ml after determination of the number of
cells microscopically in a haemocytometer.
2.4 Collection of saliva
Unstimulated saliva was collected from healthy individuals, and the samples
were centrifuged at 1000 g for 20 min. The supernatant was collected, boiled
for 20 min, recentrifuged and the supernatant stored at -20°C until used.
2.5 Bacteria
Serogroupable isolates were obtained from spinal fluid or blood of patients with
meningococcal disease. The non-groupable isolate was obtained from a carrier.
2.5.1 Culture media: Modified New York City medium
(MNYC)
MNYC medium (Young, 1978) composed of Difco Gonococcal base enriched with
10% horse blood lysed with 0.5% Saponin, 2.5% yeast dialysate, 0.1% glucose,
lincomycin (1.0 ^g/ml), colistin (6 /xg/ml), amphotericin B (1.0 /xg/ml) and
trimethoprim lactate (6.5 /ig/ml).
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2.5.2 Incubation conditions
Standard incubation conditions, unless otherwise stated, were overnight at 37°C
in an aerobic C02-enriched (10%) humidified atmosphere.
2.5.3 Storage of bacteria
All isolated were stored lyophilised at room temperature.
2.5.4 Standardization of bacterial concentration
Bacterial concentration was calibrated by comparison of numbers detected by
counting chamber (Thoma) with spectrophotometry reading at 541 nm (2xl08
bacteria/ml=0.35 O.D.).
2.6 Solutions for enzyme linked immunosorbent
assay (ELISA)
2.6.1 Coating buffer
Coating buffer was composed of 15 mM sodium carbonate, 35 mM sodium bi¬
carbonate and 3 mM sodium azide (pH
2.6.2 Washing buffer
Washing buffer was prepared by adding bovine serum albumin (BSA) (1% w/v)
and Tween-20 (0.05% v/v) to 0.01 M PBS (pH 7.2).
2.6.3 Blocking buffer
Blocking buffer was composed of 0.01 M PBS containing 1% (w/v) BSA (pH
7.2).
2.6.4 Substrate solution
The substrate solution used in the colour reaction to detect horseradish peroxi¬
dase contains 40 mg O-phenylenediamine in 100 ml of 0.1 M phosphate citrate
buffer (pH 5) activated immediately before used by adding 40 /xl H202 (30%
v/v).
2.7 Analysis of cells by flow cytometry
Analysis was done on an EPICS 'C' flow cytometer (Coulter Electronics, Luton,
UK) equipped with a 5 watt laser using a power output of 300 mw at 488
nm. The cells were selected from a display of forward angle light scatter versus
90° light scatter by means of a bit map. More than 3,000 cells were analysed
from each sample. The percentage of cells showing fluorescence greater than
the background level was recorded on a one parameter histogram, measuring
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fluorescence on a logarithmic scale. The mean fluorescence channel values for
the positive cells were acquired from a one parameter histogram, measuring
fluorescence on a linear scale. The results were analysed by the immunoanalysis
program (Coulter).
2.8 Antibody purification on Synsorb beads
Synthetic beads with blood group antigens activity provide a mean for separat¬
ing antibodies which have an affinity for the given immobilized oligosaccharide.
Synsorb beads (Chembiomed Ltd., Edmonton, Alberta, Canada) axe composed
of synthetic carbohydrate structures of known specific composition covalently
linked to an inert, insoluble matrix. For antibody purification, 20 ml of hy-
bridoma culture supernatant containing antibodies were mixed with 1 g of the
appropriate Synsorb beads overnight at 4°C. Unbound antibody was removed
and the beads washed twice with 0.01 M PBS (pH 7.2) by centrifugation at 50
g for 5 min. The antibody was eluted by mixing the beads end over end for
15 min at room temperature with 5 ml of 2% ammonia in saline (pH 11). The
beads were pelleted by centrifugation at 50 g for 5 min and the supernatant was
collected and dialysed against 0.01 M PBS. The beads were stored for further
use in 70% (v/v) ethanol at 4°C.
2.9 Coupling proteins to Sepharose 4B
Ulex turopaeus (UEAI) lectin (Sigma, Pool, Dorset, UK) and mouse monoclonal
anti-Le° Lml 12/161 provided by Dr. R.H. Fraser (Glasgow and West of Scotland
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Blood Transfusion services, Law Hospital, Carluke, Lanarkshire, UK) (Fraser
et al., 1984) were used for the purification of molecules containing H and Lea
determinants from saliva. The lectin and the antibody (purified on Synsorb
Lea, see section 2.8) were coupled to cyanogen bromide activated Sephaxose 4B
beads (Pharmacia, Uppsala, Sweden)(0.5 g of dry beads can bind up to 3.5 mg
of protein). Impurities were washed away from the beads by mixing the beads
with 10 ml of 1 mM HC1 (pH 3) for 15 min at room temperature. The beads
were pelleted by centrifugation at 50 g for 5 min. UEAI or antibody were diluted
in coupling buffer (0.1 M sodium bicarbonate + 0.5 M sodium chloride, pH 9).
The gel-protein mixture was rotated overnight at 4°C. Unbound material was
removed by centrifugation at 50 g for 5 min. The beads were washed three
times with 15 ml NET buffer (0.15 M sodium chloride + 0.04 M EDTA + 0.04
M Tris + 0.2 mM phenylmethyl sulfonyl fluoride, pH 7). Free active groups
on the gel were blocked by mixing with 1 M ethanolamine (pH 8) for 120 min.
Non-covalently bound material was removed by 3 cycles of washing with 15 ml
0.1 M acetate buffer (0.1 M sodium acetate + 1 M sodium chloride, pH 4) and
then with 15 ml 0.1 M bicarbonate buffer (0.1 M sodium hydrogen carbonate +
1 M sodium chloride, pH 8). The gel was then used for affinity purification of
blood group containing molecules from saliva.
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Chapter 3
Determination of H antigen on
cells and in saliva
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3.1 Introduction
The H blood group antigen found on various epithelial cells has been suggested to
act as an attachment site for some microorganisms (Blackwell, 1989b). Increased
susceptibility of non-secretors is explained if H determinants present in secretions
of secretors can bind to adhesins recognizing H; this might reduce bacterial
attachment to cells from these individuals. As a first step in the investigation of
this hypothesis sensitive methods for measuring the two main types of H antigen,
found on buccal epithelial cells (BEC) and in saliva, have been developed.
H Type 1 and H Type 2 differ in their chemical composition, the genes that
control their expression and their sites of production (for a recent review, see
Clausen and Hakomori, 1989). H Type 1 is the main type of H antigen found
in secretions. It is produced by fucosylation of Type 1 precursor chains. The
fucosyltransferase that synthesizes H Type 1 is coded for by the secretor gene
(Oriol et al., 1981). This antigen is not found in secretions of non-secretors since
they lack the secretor gene. The expression of H Type 2 antigen as part of the
cell membrane in different tissues is independent of secretor status. The H gene
codes for a fucosyltransferase that preferentially uses Type 2 precursor chains
(Oriol et al., 1981). Previous studies have shown that H Type 1 and H Type 2
antigens can be detected on the surface of BEC and in saliva (Dabelsteen et al.,
1982; Florry 1966; Le Pendu et al., 1982; Vedtofte et al., 1981).
The hypothesis that suggests H in body fluids as a protective mechanism
in secretors makes two assumptions: 1) secretors and non-secretors express the
same amount of H antigen on their cells and 2) secretors express large amounts
of H in their secretions compared with non-secretors. To assess the validity of
these two premises, the amount of H determinants on BEC, oropharyngeal cells
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(OPC) and nasopharyngeal cells (NPC) was measured by flow cytometry. By
this method we were able 1) to compare the expression of the two types of H
determinants in secretors and non-secretors; 2) to compare the expression of
these determinants on BEC, OPC and on NPC and 3) to investigate the uptake
of H from saliva of secretors onto BEC. The amount of H determinant in saliva
of secretors and non-secretors was determined by a simple ELISA.
3.2 Materials and methods
3.2.1 Detection of H antigen on cells
Detection of total H present (H Type 1 and 2)
Total amount of H Type 1 and H Type 2 on the surface of epithelial cells was
detected by fluorescein isothiocyanate (FITC)-conjugated UJex europaeus lectin
(UEAI, Sigma, Poole, Dorset, UK).
Detection of H Type 2
H Type 2 was detected with mouse monoclonal antibody Lm92/90 (Mackie et
al., 1984). The antibody was purified on Synsorb H Type 2 (see section 2.8)
and dialysed against saline for 24 hr at 4°C. The antibody was mixed with
0.4 ml of 0.5 M caxbonate-bicarbonate buffer (pH 9.5) and 1ml of fluorescein
isothiocyanate isomer I (Sigma) in PBS (0.4 mg/ml) was added. The mixture
was rotated for 2 hr at room temperature and than dialysed for 72 hr against
three changes of PBS (Johnson and Holborow, 1986).
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Test procedure
Two hundred microlitres of cell suspension containing 2.5x10s cells/ml were
mixed with an equal volume of FITC labelled UEAI, monoclonal antibody or
buffer in a 5 ml culture tube and incubated at 37°C for 15-60 min with con¬
tinuous shaking. The cells were washed three times with DPBS+B (300 g for
10 min) and fixed with 0.2 ml of 1% buffered paraformaldehyde (Lanier and
Warner, 1981). The cells were analysed on an EPICS'C' flow cytometer as
described in section 2.7.
3.2.2 Adsorption of H from saliva
Two hundred microlitres of a suspension of BEC (2x10s cells/ml) from secretors
or non-secretors were mixed with 200-600 n\ of undiluted secretor saliva from
a blood group O donor, who did not express Lewis antigen, in 5 ml test tubes.
The tubes were shaken for 30-120 min at 37°C and washed twice with DPBS+B
(300 g for 10 min). The amount of H antigen on the cells was determined using
UEAI and monoclonal antibody as described above.
3.2.3 Detection of H antigen in saliva
The composition of buffers used in this assay are given in section 2.6. The
wells of polystyrene microtiter plates (M129B Dynatech, Billinghurst, Sussex,
UK) were coated overnight at 4°C, with 100 /xl of ten fold dilutions of saliva in
coating buffer. All further procedures were carried out at room temperature.
The wells were washed three times with washing buffer then blocked for 15
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min with blocking buffer. The blocking buffer was removed and the wells were
washed twice with washing buffer. One hundred microlitres of biotinylated UEAI
(Sigma) diluted in blocking buffer (5 /zg/ml) were added to each well for 30 min.
After 3 washes, 100 /z 1 of a 1 /10 or 1/100 dilution of streptavidin biotinylated
horseradish peroxidase complex (Amersham, Amersham, UK) in blocking buffer
were added for 20 min. The wells were washed 3 times, and 100 of substrate
solution were added. The reaction was allowed to develop in the dark for 20
min and then stopped by adding 50 /zl of 12.5% (v/v) H2SO4. The absorbance
at 490 nm was measured using a Dynatech plate reader. Samples were run in
duplicate and the readings averaged.
3.2.4 Statistics
The Student's t-test was used for all statistical analysis.
3.3 Results
3.3.1 Detection of H antigen on cells
Ulex concentration
Ten fold dilutions of Ulex lectin were incubated with BEC from a secretor and
from a non-secretor for 30 min. The levels of H determinant detected are shown
in Figure 3.1. Above 10 /zg/ml, all the cells in the two populations were positive;
but those from the secretor had higher levels of H (mean fluorescence). Below
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Concentration of UEAI (^g/ml)
Figure 3.1: Determination of H on BEC from secretor (red) and non-
secretor (blue) using UEAI and an incubation period of 30 min. Each point
represents the results from a secretor and a non-secretor donor.
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10 /zg/ml there was a steady drop in the percentage of positive cells. UEAI
concentrations were used in subsequent assays at 10 Mg/ml or more.
Time course
Variation in the amount of fluorescence with incubation period is shown in Figure
3.2. At the concentration of Ulex used (30 /ig/ml) an incubation period greater
than 15 min did not result in an increase in the amount of H detected on cells
from the secretor. This point also showed the biggest difference between the
secretor and the non-secretor cells. In the subsequent experiments, cells were
incubated with UEAI for 15 min.
Total amount of H on cells from secretors and non-secretors
Figure 3.3 shows the levels of H antigen detected with UEAI on BEC from
secretors and non-secretors measured by flow cytometry. The total amount of
H antigen on BEC was between 3.5-6 times greater for secretors than for non-
secretors, depending on UEAI concentration. This difference was statistically
significant for the three concentrations of UEAI used in this study (p<0.001).
Almost all the BEC (90-99%) in the two populations expressed the H antigen;
but, a greater amount of antigen, as determined by mean channel, was present
on secretor cells. Figure 3.4 shows two distinct peaks for the two populations
of BEC analysed. Cells obtained from a non-secretor (peak 'a') show a lower
mean fluorescence compared to cells from a secretor donor (peak 'b'). More
than 90% of the cells in each population show fluorescence levels higher than
the background level, indicated by the cursor on the left of the histogram. A











Figure 3.2: Time course for determination of H on BEC from secretor (red)
and non-secretor (blue) using UEAI. Each point represents the results from a

















Concentration of UEAI (/zg/ml)
Figure 3.3: Flow cytometric determination of H on BEC from secretors
(red) and non-secretors (blue). Points represents the mean fluorescence of cells




Figure 3.4: Flow cytometric comparision of UEAI (20 jug/ml) binding to
non-secretor (a) and secretor (b) BEC. Cursor set to give 1% background level.
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cells (OPC) and nasopharyngeal cells (NPC) from a secretor and a non-secretor
(Figure 3.5). For all three types of epithelial cells tested, cells from secretors
expressed higher levels of H compared with cells from a non-secretor.
Detection of H Type 2 on BEC
There was no significant difference in the amount of H Type 2 on BEC of se¬
cretors and non-secretors, as detected by monoclonal antibody used at two con¬
centrations (Figure 3.6).
3.3.2 Adsorption of H onto BEC
Incubation period and saliva volume
Detection of H on BEC from a non-secretor after incubation with saliva speci¬
mens from secretors are shown in Figure 3.7. Under the experimental conditions,
the amount of saliva used and the length of the incubation did not influence sig¬
nificantly the amount of H detected on the cells. In the following experiments
200 /zl of saliva were incubated with cells for 1 hr.
H levels after incubation with secretors' saliva
The levels of total H and H Type 2 on cells from secretors and non-secretors
before and after incubation with saliva from a secretor are shown in Figure 3.8.
After incubation of BEC from non-secretors with secretor saliva, there was a
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Figure 3.5: Detection of H using UEAI (20 jug/ml) on buccal epithelial
cells (BEC), oropharyngeal cells (OPC) and nasopharyngeal cells (NPC) from






























Dilution of Anti-H type 2
Figure 3.6: Determination of H Type 2 on BEC from secretors (red) and
non-secretors (blue). Points represents the mean fluorescence of cells obtained
from different individuals. Bars represent ±1SEM of 7-8 individuals tested.
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Time (min)
Figure 3.7: Detection of H by UEAI on DEC from a non-secretor after















Se NS Se NS
UEAI Anti-H2
Figure 3.8: Determination of H by UEAI and anti-H Type 2 on secretor's
and non-secretor's BEC before (red) and after (blue) incubation with secretors'
saliva. Bars represent ±1SEM of four experiments.
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by UEAI. There was no significant change in the levels of H when secretor cells
were incubated with secretor saliva. The amount of H Type 2 antigen on the
cells of either secretors or non-secretors, did not change significantly following
incubation with saliva.
3.3.3 Detection of H in saliva
Streptavidin dilution
The amount of streptavidin required to detect the maximum level of H was
determined by varying the streptavidin concentration at two dilutions of saliva
(Figure 3.9). The maximum amount of H in the two dilutions of secretor's saliva
was obtained at a dilution of 1/100 of streptavidin. In the following experiments,
streptavidin was used at 1/100 dilution.
H levels in saliva of secretors and non-secretors
The presence of H determinant can be measured in secretors' saliva at a dilu¬
tion of 105 by the ELISA system developed (Figure 3.10). At all dilutions of
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Streptavidin dilution
Figure 3.9: Detection of H by ELISA in secretor's saliva diluted 1/10
(black) and 1/100 (green) at various dilutions of streptavidin. Each point rep¬






























Figure 3.10: Measurement of H in saliva from secretors (red) and non-
secrctors (blue) by ELISA. Points represents the mean fluorescence of cells ob¬




Two sensitive methods for the determination of H antigen were developed in this
study. Development of these methods was the initial step in the investigation
of the expression of H determinants on cells and in secretions of secretors and
non-secretors. This information was needed to examine the hypothesis that H
might be a receptor for bacteria. Flow cytometric analysis of BEC with FITC-
labelled UEAI measured the total amount of H antigen; and with monoclonal
antibody to H Type 2, the amount of H Type 2 antigen was determined. The
biotin streptavidin ELISA can be used to measure the amount of H in saliva.
UEAI detects both H Type 2 and H Type 1; it can agglutinate red blood cells by
their H Type 2, and this agglutination can be inhibited by H Type 1 in secretor
saliva. This lectin does not react with the native H Type 1 but with deacetylated
H Type 1 (Hindsgaul et al., 1985); therefore, the definition of secretor status is
based on deacetylated H Type 1 and not the native structure. In this study H
Type 1 refers to the deacetylated form since Ulex europaeus was used for the
detection of H.
In flow cytometry analyses, virtually all BEC from secretors and non-secretors
express the H determinant; however, as indicated by the mean fluorescence level
measured, secretors and non-secretors differ in the amount of antigen expressed
on their cells. Depending on the concentration of UEAI used, secretors had be¬
tween 3.5-6 times more H determinant on their BEC surface than non-secretors.
Similarly, NPC and OPC from a secretor had higher levels of H than cells from
similar sites obtained from a non-secretor. In contrast, there was no difference
in the amount of H Type 2 detected on cells of secretors compared with non-
secretors using the monoclonal antibody. The difference in the level of H on
BEC from the two groups appears to be due to H Type 1. These observations
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support the work of Oriol et al. (1981). According to their hypothesis, there
are two fucosyltransferases responsible for the production of H antigen; one is
controlled by the secretor gene, preferentially reacting with Type 1 chains; and
the other, controlled by the H gene, preferentially reacts with Type 2 chains.
Since both secretors and non-secretors express the H gene product, no differ¬
ence was found in the amount of H Type 2 on cells of secretors compared with
non-secretors.
In this study the increased amount of H on secretors cells is attributed to
H Type 1 resulting from the action of the secretor gene product. Incubation of
non-secretor cells with secretor saliva showed that molecules containing the H
determinant can be adsorbed from saliva onto the cell surface. The increase in
the amount of H was detected with UEAI and not with anti-H Type 2. These
results suggest that H Type 1 antigen present in secretor saliva can be adsorbed
onto the epithelial cell surfaces in a way similar to that described for the Lewis
antigen (Marcus and Cass, 1969). This explains the difference found in the
amount of H detected by Ulex on cells of secretors and non-secretors. Although,
as suggested by Le Pendu et al. (1982), the secretor gene product might be able
to fucosylate precursor Type 2 chain, the results presented here indicate that the
H Type 2 antigen is not present in saliva. The level of H Type 2 on BEC from
non-secretors did not increase after incubation with secretor's saliva (Figure
3.8). BEC of secretors did not show an increase in the amount of H following
incubation with saliva, suggesting their cell surfaces are already saturated with
this antigen. Since saliva contains glycoproteins and small amounts of glycolipids
carrying blood group determinants, the nature of the carriers of the blood group
determinants adsorbed by the cells is not known.
The ELISA developed in this study provides a simple and sensitive method
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to measure the amount of H present in saliva and to determine secretor sta¬
tus. In contrast to the haemagglutination inhibition test, commonly used for
determination of secretor state, this method is quantitative rather than qualita¬
tive. With the ELISA system, a large number of samples can be analysed in a
very short time without the requirement for fresh human red blood cells. At a
1/10 dilution of saliva, large differences in the amount of H in specimens from
secretors and non-secretors were clearly demonstrable..;, The small amount of
H detected in non-secretors' saliva is probably due to H antigen derived from
epithelium or contaminating blood cells.
One of the hypotheses investigated in this study proposes that H in secretions
of secretors can reduce colonization of epithelial surfaces of secretors. The results
described in this chapter confirm the premise that secretors have high levels of
H determinant in their secretions compared with non-secretors. The results
contradict the second premise that the amounts of H on cells of secretors and
non-secretors are similar; cells from secretors were found to express more H
than cells from non-secretors. If H is an attachment site for the bacteria, cells
of secretors should bind more bacteria than cells of non-secretors. H can be
proposed as a receptor to explain the decreased proportion of secretors among
patients, if H in secretions has higher affinity for the bacteria than H on cells or
if H is found in very high levels in secretions. To further investigate the role of
H as a receptor for bacterial binding, the attachment of bacteria to BEC from
secretors and non-secretors was investigated.
There are additional applications for this method to studies in oncology. The
blood group antigens normally present in epithelium are reported to be partially
or completely lost by neoplastic cells (Dabelsteen and Pindborg, 1973; David-
sohn et al., 1966; Prendergast et al., 1968). Accurate determination of blood
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group antigens expressed on cells by the method described in this study might
be useful in early diagnosis of malignancies as previously suggested (Dabelsteen
and Fulling, 1971; Davidsohn et al., 1969; Davidsohn et al., 1971).
This ELISA for detection of H can also be applied to the determination
of secretor status using other body fluids such as nasopharyngeal secretions,








Specific adherence of microorganisms to epithelial cells is an important step in
the colonization process. Although non-specific factors such as surface charge,
pH, ionic bridging and hydrophobic interactions might be important (Watt and
Ward, 1980), it has been argued that the attachment of bacteria to host cells is
facilitated by specific interactions. Specific interaction might be necessary since
the surfaces of both host and bacteria have a net negative charge. This mutual
repulsion could be overcome by interaction of surface molecules which act as
ligands (Ofek and Beachey, 1980). The observation that some microorganisms
show site or cell specificity, i.e. selectively binding to a receptor on certain cell
types, supports this hypothesis. This has been demonstrated by Stephens and
McGee (1981) for N. meningitidis, which bind specifically to human nasopha¬
ryngeal cells.
Early investigators of meningococcal pathogenesis implicated the nasophar¬
ynx as the natural habitat of the meningococcus. This was suggested to be the
site from which the organism was transmitted to other individuals and as the
initial site of mucosal multiplication (see Stephens and Whitney, 1985). Once
infection is established, internalization of the bacteria by epithelial cells and
transport of the organisms across the normally protective mucosal barrier is
possible (Stephens, 1989). Colonization can result in asymptomatic meningo¬
coccal carriage; in non-epidemic periods, about 5-10% of the population carry
the bacteria in the nasopharynx without adverse effects (Greenfield et al., 1971).
Despite the importance of colonization in the pathogenesis of meningococcal
disease, only recently has this aspect of the biology of N. meningitidis been
studied. The host factors involved in the attachment of meningococci are still
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poorly understood. An epidemiological study of an outbreak of meningitis in a
school found that non-secretors of blood group antigens were over-represented
among carriers of meningococci (Blackwell et al., 1990). This data suggests
that differences at the mucosal surfaces of secretors and non-secretors might
contribute to differences in colonization by the bacteria and, consequently, to
disease susceptibility.
A flow cytometric assay was developed to examine the hypothesis that there
might be differences between secretors and non-secretors in the number or dis¬
tribution of ligands involved in bacterial attachment to epithelial cells. Using
this assay the attachment of bacteria to epithelial cells from the two populations
was compared.
4.2 Materials and methods
4.2.1 Detection of bound bacteria with antibody
Two strains of N. meningitidis were used to standardize the binding assay:
serogroup C serotype 2b serosubtype Pi.2 (C:2b:Pl.2) and serogroup B serotype
15 serosubtype PI.16 (B:15:P1.16). Bacteria grown overnight were collected
from MNYC plates, suspended in PBS and washed three times by centrifuga-
tion at 1000 g for 20 min. The bacterial concentration was adjusted to give a
BEC:bacteria ratio of 1:5000 in the final mixture. Two hundred microlitres of
BEC were mixed with 100 fi\ of the bacterial suspension or buffer in 5 ml culture
tubes and incubated at 37°C for 30 min with continuous shaking. All further
incubations were carried out at 4°C with continuous shaking. The cells were
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washed three times with DPBS+B and 200 fi1 of the same buffer containing 5%
normal rabbit serum was added for 15 min. After washing once with DPBS+B
(300 g for 10 min), 100 /xl of rabbit polyclonal meningococcal serogrouping
serum (serogroup C and serogroup B) (Wellcome, Beckenham, UK) diluted in
DPBS+B were added and incubated for 30 min. As a control, buffer was added
in place of the antibody. Cells were washed three times with DPBS+B (300
g for 10 min) and 100 /xl of FITC conjugated donkey anti-rabbit immunoglob¬
ulin (Scdtish Antibody Production Unit, Carluke, Lanarkshire) in DPBS+B
added to each tube. The mixtures were incubated for 30 min and washed three
times with DPBS+B. The cells were fixed with 1% buffered paraformaldehyde
and analysed in an EPICS'C' flow cytometer (see section 2.7). For each sample
analysed two parameters were obtained; 1) the percentage of cells in the popula¬
tion that showed fluorescence levels higher than the background (cells incubated
without bacteria); 2) the mean level of fluorescence in the population of positive
cells, reflecting the mean number of bacteria bound to the cells.
4.2.2 Labelling the bacteria with FITC
4.2.2.1 Method 1
The first technique is a modification of the method described for labelling anti¬
body with FITC (Johnson and Holborow, 1986). A heavy suspension of bacteria
in PBS was prepared from colonies grown overnight on MNYC plates. Bacteria
were washed three times in PBS by centrifugation at 1000 g for 20 min. Four
hundred micrograms of FITC were dissolved in 1 ml of PBS and sonicated in
an ultrasonic-bath (Astell Scientific, London, UK) for 5 min. Two hundred mi-
crolitres of 1 M carbonate-bicaxbonate buffer (pH 8.9) were mixed with 100 n\
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of the FITC mixture, added to the pellet of bacteria and incubated at 37°C for
2 hr with continuous shaking. Free FITC was removed by washing three times
with PBS at 1000 g for 20 min.
4.2.2.2 Method 2
This method is a modification of that described by Wright and Jong (1986).
A heavy suspension of bacteria in PBS was prepared and washed as described
above. Four hundred micrograms of FITC were dissolved in 1 ml buffer (0.05 M
sodium carbonate + 0.1 M sodium chloride, pH 9.2) and added to the bacteria
pellet. The mixture was incubated at 37°C for 20 min and washed three times
as described for method 1.
4.2.3 Attachment assay
N. meningitidis serogroup C strains directly conjugated with FITC were used in
this assay. After labelling, the bacterial concentration was adjusted to produce
the required ratios of epithelial cells to bacteria in the final mixture. Two hun¬
dred microlitres of epithelial cells were mixed with 100 fj. 1 of each dilution of bac¬
teria or buffer in a 5 ml culture tube and incubated at 37°C for 0-120 min with
continuous shaking. The cells were washed three times with DPBS+B by cen-
trifugation at 300 g for 10 min and fixed with 1% (v/v) buffered paraformalde¬
hyde. Experiments were performed to study the effect on meningococcal attach¬
ment of: time, pH, fixation of BEC and sonication of BEC. The bacteria were
mixed with the BEC for periods ranging from 0 to 120 min. The effect of pH on
attachment was assessed by adjustment of the DPBS+B buffer to the desired
pH by the addition of NaOH or HC1. Fixation was examined by treatment of
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the BEC with buffered paraformaldehyde for 20 min prior to incubation with
bacteria. The BEC were washed twice in DPBS+B before adding the bacteria.
The effect of sonicating BEC before incubation with bacteria was studied by
sonicating the cells in an ultrasonic-bath (Astell Scientific, London, UK) for 5
min prior to adding the bacteria. The role of Ca2+ ions was determined by
washing the BEC twice with DPBS containing 10 mM EDTA before adding the
bacteria in DPBS+EDTA (10 mM).
The binding of different serotypes of N. meningitidis to BEC and attachment
to cells from secretors and non-secretors were also studied.
The samples were analysed by the flow cytometer as described in section
2.7. Results were expressed as the mean fluorescence level or by an attachment
index obtained by multiplication of the percentage of positive cells by the mean
fluorescence. This value gives an indication of the total fluorescence in a cell
sample.
4.2.4 Statistics
For comparison of attachment of meningococci to BEC of secretors and non-
secretors, the results for the non-secretor were expressed as percentage of the
secretor, calculated by the formula: [(non-secretor - secretor) / secretor] x 100.
These values were used in the Student-t test to calculate confidence intervals.
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4.3 Results
4.3.1 Detection of bacterial binding with antibodies
Bound bacteria were detected with a rabbit anti-capsular antiserum. The pres¬
ence of bound antibody was determined with FITC conjugated antibody to
rabbit immunoglobulin. Three controls, without bacteria, were included: cells
alone, cells with FITC conjugated anti-rabbit immunoglobulin and cells with
both antibodies. The fluorescence levels of control cells incubated with antibod¬
ies and test cells incubated with bacteria and antibodies were compared to the
background fluorescence level (cells only). As shown in Table 4.1, the fluores¬
cence levels obtained for the controls with the antibodies were higher than the
background level. More than 70% of the cells in the two samples bound the
FITC conjugated antibody. A higher percentage of positive cells was found af¬
ter incubation with anti-capsule and anti-rabbit antibodies compared with cells
incubated with anti-rabbit antibody only. The values obtained for cells that
had been incubated with bacteria were not markedly different from the controls
for the two strains of bacteria used. These results indicated that both anti¬
bodies used were binding to structures on the BEC. Since higher readings were
found for the controls this method could not be used for the study of bacterial
attachment to BEC.
4.3.2 Labelling bacteria with FITC
Two methods for directly labelling the bacteria with FITC were compared. It
can be seen from Figure 4.1 that the mean fluorescence level of attachment when
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Table 4.1: Detection of bacterial binding to BEC using antibodies
Cells Group C Group B
% mean % mean
Cells A:
Control 1 77 150 77 150
Control 2 95 230 87 185
Test 73 261 90 190
Cells B:
Control 1 72 218 72 218
Control 2 81 150 78 156
Test 71 124 64 122
BEC from two individuals (cells A and cells B) were incubated with two
strains of bacteria B:15:P1.16 (group B) and C:2b:P1.2 (group C). Two
controls were used: BEC + anti-rabbit immunoglobulin (control 1) and
BEC + anti-bacteria + anti-rabbit immunoglobulin (control 2). In the test a
BEC:bacteria ratio of 1:5000 was used.
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bacteria were labelled by method 2 was higher than with method 1 (3.5 times).
The attachment of bacteria to BEC was more uniform with the second staining
method. The second method is also more convenient to use since the sonication
stage is not required and the incubation period is shorter. In the following




The attachment of bacteria to BEC from a secretor donor was measured using
80 and 40 bacteria per cell at four incubation periods (Figure 4.2). A similar
pattern was obtained for the two ratios of bacteria per cell used. No attachment
was observed when the BEC and bacteria were mixed and immediately washed
(time 0). Attachment increases rapidly over the first 60 min after which the
rate appears to slow down. Incubation for 30 min gave significant attachment
to BEC at the two ratios used. This point is also in the middle of the initial
rapid binding period and will allow detection of increases or decreases in at¬
tachment. Therefore, 30 min was used as the incubation period in the following
experiments.
4.3.3.2 The effect of pH
The attachment of bacteria to BEC, at the ratio of 40 bacteria per cell, did not




Figure 4.1: Flow cytometric comparision of bacterial binding to BEC using
FITC conjugated bacteria prepared by: method 1 (a) and method 2 (b). The
peaks represent cells with fluorescence level higher then the background (no
bacteria).
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Figure 4.2: The effect of time on the attachment of FITC labelled N.
meningitidis (C:2b:Pl.2) to BEC. The level of attachment was determined by
flow cytometry after the BEC were incubated with 40 (black) or 80 (red) bacteria
per cell.
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the following experiments the physiological pH (7.2) was used.
4.3.4 Attachment of meningococci to BEC and pharyn¬
geal cells
Binding of N. meningitidis to BEC, and cells obtained from the oropharynx
and the nasopharynx was demonstrated (Table 4.2). The three populations of
cells differ in their size, therefore the attachment level (mean fluorescence) is
not comparable. Since BEC are easier to obtain, they were further used in this
study.
4.3.5 Attachment of three strains ofmeningococci to BEC
Three serotypes of N. meningitidis serogroup C (2b, 4 and 2b.Pi.2) were tested
for their ability to bind to BEC by the attachment assay developed in this study.
The three strains used showed a similar pattern of bacterial attachment at the
three doses of bacteria used and under the following experimental conditions:
incubation at 37°C for 30 min, pH 7.2 and in the presence of Ca2+ and Mg2+
ions (Figure 4.4).
4.3.6 Attachment ofmeningococci to BEC from secretors
and non-secretors
The attachment of N. meningitidis serogroup C to BEC from secretors and non-
secretors was compared at three ratios of bacteria per cell. For each BEC sample
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Figure 4.3: The effect of pH on the attachment of FITC labelled N. menin¬
gitidis (C:2b:P1.2) to BEC from a secretor (red) and a non-secretor (blue),
detected by flow cytometer.
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Table 4.2: Attachment of bacteria to BEC, OPC, and NPC
BEC OPC NPC
% 99 84 94
Mean 670 115 262
The percentage of positive cells and the mean level of fluorescence
obtained after incubation of epithelial cells with bacteria at a ratio of 80
bacteria per cell. The epithelial cells used: buccal epithelial cells (BEC),
oropharyngeal cells (OPC) and nasopharyngeal cells (NPC), were obtained
from a non-secretor donor.
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Figure 4.4: Binding of three strains of N. meningitidis: C:2a (black), C:4
(red) and C:2b:Pl.2 (blue), to BEC from one donor. Similar results obtained
for BEC from three other donors.
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an index was obtained as described in section 4.2.3. The indices were used in
Figure 4.5 to compare bacterial attachment between pairs of secretors and non-
secretors. The attachment to non-secretor cells was expressed as a percentage
of the secretor cells. Although at the lower ratios of bacteria to cell, BEC of
non-secretors bound more bacteria than those of secretors, the difference was
not statistically significant at any of the three ratios used. As the number of
bacteria per cell decreased, the mean of the difference increased, indicating more
bacteria were attached to BEC from non-secretors than to BEC from secretors.
The 95% confidence limit, represented by the bars, indicates the probability
that non-secretors cells bind more bacteria than secretors cells. Reducing the
bacteria to cell ratio resulted in an increased probability that non-secretors cells
bind more bacteria. At the lowest ratio used, the results were just outside the
95% confidence level.
4.3.7 The effect of fixation, EDTA and sonication on bac¬
terial binding
Treating the cells with buffered paraformaldehyde, sonication or EDTA reduced
the attachment of bacteria to cells (Table 4.3). Fixation of cells prior to incu¬
bation with bacteria reduced the mean level of bacterial binding per cell by up
to 60% compared with the attachment to untreated cells. The effect of treating
the cells by sonication or EDTA was not as strong as that observed for fixation
(between 40-50% decrease). The same pattern was observed for treatment of


























Figure 4.5: Attachment of N. meningitidis C:2b:Pl.2 to BEC from secretors
and non-secretors. Each point represents the average difference between 8 pairs
of secretors and non-secretors. The bars show 95% confidence limit.
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Table 4.3: The effect of fixation, sonication and EDTA on attachment to
BEC
Cells Mean fluorescence
Normal Fixed Sonicated EDTA
Secretor 180 67 125 109
Non-secretor 193 88 93.2 120
Mean fluorescence levels obtained for BEC from a secretor and a non-
secretor donor, when cells were not treated (normal), fixed with buffered
paraformaldehyde, sonicated or treated with EDTA.
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4.4 D iscussion
The early stage of infection with pathogenic Neisseria is determined by receptor-
mediated events that result in colonization and invasion of human mucosal tis¬
sues. Despite the importance of this initial step in carriage of the bacteria and in
infection, very little is known about the molecules interacting in the process of
attachment. A major problem in studying the pathogenesis of meningococci is
the specificity of the disease for humans. This fact has limited the use of animal
models in studies of the pathogenesis of this organism. The potential severity of
the diseases caused by meningococci has limited direct human experimentation.
To overcome this problem, the attachment of meningococci to epithelial cells has
been studied in vitro by cell and organ culture assays involving predominantly
cells and tissue of human origin.
Human buccal epithelial cells have been favoured for use in attachment as¬
says because they are easily obtained. However, there are several factors to be
considered: 1) the cells obtained by scraping the buccal mucosa are not uni¬
form in the degree of maturation, viability and size; 2) the structure of the cells
is influenced by hormonal factors and other variables that are not easily con¬
trolled; 3) many of the cells already have bacteria (oral flora) attached to their
surfaces and 4) the buccal mucosa is not normally colonized by Neisseria menin¬
gitidis. Despite those drawbacks, BEC have been extensively used in studies of
meningococcal attachment (Trust et at., 1983; Salit and Morton, 1981; Stephens
and Whitney, 1985; Stephens et at., 1988).
In addition, the attachment of N. meningitidis to erythrocytes (Trust et
at., 1983; Salit and Morton, 1981), nasopharyngeal cells (Stephens et at., 1983),
oropharyngeal cells (Salit and Morton, 1981) and nasopharyngeal tissue in organ
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culture (Stephens et al., 1987) has been studied.
In this study we compared the attachment of meningococci to secretors and
non-secretors of ABO blood group antigens, which required examination of a
large number of donors from both populations. In this case, the availability of
cells is an important factor. The aim of this study was to test the influence of
blood group determinants associated with the expression of the Se gene (Lea
and H) on the attachment of N. meningitidis to epithelial cells. Therefore, in
section 3.2.1, the expression of H determinant on pharyngeal cells (the natural
site for colonization by meningococci) and BEC was compared. As was shown in
Figure 3.5, BEC and pharyngeal cells of a secretor expressed higher levels of H
determinants compared with the cells of a non-secretor. The level of expression
of ABH blood group antigens on both types of cells seems to be under the
control of the Se gene. Although BEC are not the natural site for colonization
by meningococci, they appear to be suitable model for studying the influence of
the expression of these determinants on attachment.
As a first step in setting up the attachment assay, an indirect method for de¬
tection of bound bacteria with antibodies was tested. As shown in Table 4.1, this
system gave high background due to cross-reactivity between bacterial antibod¬
ies and antigens present on the BEC. Therefore, another system for detection of
bound bacteria was developed in which bacteria were directly conjugated with
FITC.
Bacterial attachment was observed using buccal epithelial, nasopharyngeal
and oropharyngeal cells from a non-secretor (Table 4.2), but the levels were not
comparable since the cells differ in their size. These results are in agreement
with previous studies that have demonstrated attachment of N. meningitidis to
these three types of cells (Salit and Morton, 1981).
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In previous studies, quantification of attachment of meningococci to human
cells was tested by several methods. Haemagglutination was used for deter¬
mination of attachment to erythrocytes. This test was also used to detect the
expression of pili on the bacterial surface (Trust et al., 1983). Radiolabelling the
bacteria was used to quantitate the attachment of meningococci to BEC. This
method was used to determine the proportion of bacteria that bind to the cells,
but did not give information for the proportion and distribution of attachment
on the cells (Trust et al., 1983). A common method used for the assessment of
bacterial binding to cells is the use of light microscopy to detect bound bacteria
after staining by Gram's method (Salit and Morton, 1981). With this method
relatively small number of cells are examined (50-100) and there are problems
differentiating between the normal flora and meningococci (Salit and Morton,
1981).
In this study a flow cytometric method was developed for determination of
attachment of fluorescein-labelled bacteria to epithelial cells. Using this method
the percentage of cells that bind bacteria as well as the mean level of binding are
obtained. This method overcame some of the drawbacks associated with the use
of BEC for attachment studies. First, unlike counting the number of bacteria
bound to cells by light microscopy, attachment assessed by the flow cytometer
is objective. Second, large number of cells (>3,000 cells in each sample) can be
analysed in a short period of time (100 cells in a second). This allows rapid
examination of large numbers of cells from a large group of donors. In addition,
the method overcame the wide variation in the numbers of bacteria bound to
cells obtained from an individual. As indicated by the standard error, the vari¬
ation is very low (less then 3% of the mean fluorescence). Variation between
donors resulting from hormonal changes and other factors are still a problem
which is difficult to control; but a large population of donors should compen-
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sate for these variations. To reduce as much as possible variation resulting from
differences between individuals, secretors and non-secretors tested were paired
according to their ABO blood group, sex and age. The sample size was limited
by the number of non-secretor donors available. Hence, difficulties in obtaining
significant differences in attachment to BEC between the two populations might
result from the wide variation in the population.
Under the experimental conditions used, attachment of bacteria to BEC was
decreased when the cells were fixed, sonicated or treated with EDTA (Table 4.3).
Fixation of cells influences the fluidity of the cell membrane. This could effect
the ability of the receptors to move in the membrane and therefore interfere with
bacterial binding. The presence of Ca2+ and Mg2+ ions seems to play a role in
part of the interactions between the bacteria and the cells. This might indicate
the involvment of lectin-like interactions, in which the presence of Ca2+ is known
to be required (Cook and Bugg, 1975). Sonication of the cells before attachment
reduced bacterial binding. This could result from elimination of some of the
receptors on the cells surface in the process of sonication. After setting up the
experimental conditions, attachment of one strain of N. meningitidis to BEC
from secretors was compared with attachment to BEC from non-secretors. The
serogroup C strain used is one isolated recently from a patient in Scotland where
the presence of disease due to group C strains is increasing (R.J. Fallon, personal
communication).
Two hypotheses were tested in this study. The first suggested that bacteria
have adhesins that can bind to the H epitopes. In the second, the Lea determi¬
nant is proposed as the receptor for bacterial binding. If the first is correct, cells
from secretors should bind more bacteria than cells from non-secretors, since se¬
cretors express far more H determinants on their cells compared to non-secretors
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(see section 3.3.1). If Lea is the receptor, since non-secretors express far more
Lea on their cells compared with secretors (Vedtofte, 1985), they should bind
more bacteria. In the attachment experiments, BEC from non-secretors were
found to bind more bacteria than cells from secretors; the difference was not
statistically significant (0.05<p<0.1), but may support the hypothesis that Le°
is a receptor for the bacteria.
Although the Le° determinant is found in greater quantity among non-
secretors, it is present in both secretors and non-secretors. These results might
reflect the variable amounts of Lea present on cells of secretors. Although se¬
cretors express Le6 predominantly, some of these individuals have substantial
amounts of Lea in their body fluids (Ogata et al., 1988) and, therefore, on their
epithelial cells.
As the ratio of bacteria to epithelial cells was decreased, the increased binding
of meningococci to cells of non-secretors became more apparent. In our system,
incubation of BEC with bacteria at a ratio of 1:20 is the lowest ratio that gives
fluorescence levels above the background. These lower ratios might reflect more
closely the in vivo situation in which the numbers of bacteria per cell are limited.
Higher levels of attachment to epithelial cells from non-secretors compared
with cells from secretors was reported for uropathogenic strains of E. coli (Lom-
berg et al., 1986) and Candida blastospores (May et al., 1986). Urinary tract
infections due to E. coli and superficial infections due to Candida have been
associated with non-secretion of blood group antigens (Blackwell et al., 1989b;
May et al., 1989; Thorn et al., 1989).
Most of the experiments in this chapter used one strain of meningococci
for developing the assay and for testing the attachment to secretors and non-
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secretors cells. The results shown in Figure 4.4 indicate that the system is
suitable for testing other strains; and the results obtained for the one strain may
be extended for other strains and species of bacteria with the assay developed.
Since higher levels of attachment were obtained with cells from non-secretors,
we concluded that H is not a binding site for the strain tested.
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Chapter 5
Possible role for Lewisa




In chapter 4, BEC from non-secretors were found to bind more bacteria than
BEC from secretors. The only determinant known to be present in higher levels
on cells from non-secretors compared with cells from secretors is the Lea blood
group determinant. Therefore the role of this structure as a receptor for bacterial
binding was further investigated.
The Lewis determinants are found as glycosphingolipids and glycoproteins in
serum and body secretions. This antigen is not produced endogenously by red
blood cells; it is adsorbed from serum onto the cells (Marcus and Cass, 1969).
The antigens have been shown to be present on many tissues including buccal
epithelium (Vedtofte, 1985).
The type of Lewis determinant expressed in an individual depends on the
presence of the St gene. The Lewis determinants are produced by fucosylation of
precursor Type 1 or H Type 1 by a fucosyltransferase coded by the Lt gene. This
gene is expressed in 90-93% of the population and is inherited independently
of the St gene. The type of acceptor molecule used will determine the type of
Lewis determinant produced. Fucosylation of precursor Type 1 results in the
expression of Le° and when H Type 1 is fucosylated Le6 is produced. The St and
Lt gene products can both fucosylate precursor Type 1 (see Figure 1.5). When
the two genes are expressed (i.e. in secretors, Lewis-positive individuals), the
ratio of expression of the two types of Le determinants depends on the efficiency
of the two enzymes. In most cases, the Se enzyme is more efficient; therefore,
most of the precursor molecules are converted to H Type 1 and then to Le\
When the Se enzyme is less efficient, a larger proportion of the precursor chain is
converted to Lea which cannot be further fucosylated by the Se enzyme. Hence,
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in secretors varying amounts of Lea and Lek are present; but in non-secretors,
since the Se gene is not expressed, only Le° is produced.
In this part of the study, a role for the Lea determinant in bacterial attach¬
ment was investigated by two methods. 1) The ability of bacteria to adsorb
partially purified Le° from suspension was examined. If the bacteria have ad-
hesins that can bind Le°, incubation of bacteria with molecules containing this
determinant should result in a decrease in the amount of Lea determinants in
the preparations. To measure the amount of Lea in solution an ELISA method
was developed. 2) Pretreatment of the bacteria with partially purified molecules
containing Lea prior to incubation with BEC was studied. This was compared
to pretreatment of bacteria with saliva.
5.2 Materials and methods
5.2.1 Development of an ELISA to measure Lea
Composition of the buffers used in the ELISA are given in section 2.6.
5.2.1.1 Coating the plate with anti-mouse immunoglobulin antibody
The wells of polystyrene microtitre plates (M129B Dynatech, Billinghurst, Sus¬
sex, UK) were coated overnight at 4°C with 100 jd of rabbit anti-mouse im¬
munoglobulin (DAKO Ltd., Bucks, UK) in coating buffer (60 /ig/ml). All further
procedures were carried out at room temperature. The wells were washed three
times with washing buffer and incubated with 150 /zl of blocking buffer for 15
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min. The buffer was then removed and the wells were washed twice with washing
buffer. Mouse monoclonal anti-Lea Lmll2/161 (100 jzl) provided by Dr. R.H.
Fraser (Glasgow and West of Scotland Blood Transfusion Service, Law Hospital,
Carluke, Lanarkshire, UK) (Fraser et al., 1984) in blocking buffer (100 /d) was
added for 1 hr. Unbound antibody was removed by washing three times with
washing buffer. One hundred microlitres of ten fold dilutions of saliva in block¬
ing buffer were added for 30 min. After washing three times with washing buffer,
100 fx 1 of a goat anti-Le° serum (Behring, Marburg, W. Germany) diluted 1/100
in blocking buffer were added for 30 min. The wells were washed 3 times and
100 jd of horseradish peroxidase-conjugated donkey anti-goat immunoglobulin
(Scottish Antibody Production Unit, Carluke, Lanarkshire, UK) diluted 1/250
in blocking buffer added. The plate was incubated for 2 hr, washed 3 times and
100 /d of substrate solution added. The reaction was allowed to develop in the
dark for 20 min and stopped by adding 50 /xl of 12.5% (v/v) H2S04. Absorbance
at 490 nm was measured with a Dynatech plate reader. Samples were tested in
duplicate and the readings averaged.
5.2.1.2 Coating the plate with Synsorb purified antibody
The method described above was modified so that the plate was coated overnight
at 4°C with monoclonal anti-Lea that had been purified on Synsorb Le° (see
section 2.8). After washing and blocking as described above, 100 /d of test
samples diluted in blocking buffer were added for 30 min. Unbound antigen was
removed by washing 3 times with washing buffer. The polyclonal anti-Lea was
added and the rest of the procedures were carried out as described above.
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5.2.2 Purification of Lea containing molecules
A modification of the method described by Pak et al. (1984) was used to iso¬
late Lea containing molecules from saliva of a non-secretor donor. Unstimulated
saliva specimens (20 ml) were collected from healthy individuals and centrifuged
at 1000 g for 20 min. The supernatant was collected, boiled for 20 min, recen-
trifuged, freeze dried and resuspended in 6 ml of distilled water. The concen¬
trated non-secretor saliva (6 ml) was mixed with 1.5 ml of swollen anti-Lea
Sepharose 4B beads(see section 2.9). After overnight incubation at 4°C the su¬
pernatant was removed and the Sepharose beads washed three times with 15
ml NET buffer (0.15 M NaCl, 0.04 M ethylenediamine tetraacetic acid, 0.04 M
Tris, 0.2 mM phenylmethylsulfonyl fluoride, pH 7). The antigens were eluted
by incubation with 3 ml of 1 M acetic acid for 30 min at 20°C with continuous
rotation. The eluate was dialysed against 3 changes of PBS. The presence of Lea
determinants was tested using the ELISA system as described in section 5.2.1.2.
5.2.3 Adsorption of Lea by bacteria
The strains of bacteria used in this assay are shown in Table 5.1. Preparations
of molecules containing Lea determinants (150 /zl) were incubated with an equal
volume of bacterial suspension (105 bacteria per ml) or buffer in V well mi-
crotitre plates (M25A Dynatech). The positive control was antigen preparation
with buffer and the negative control was bacteria with buffer. The plate was
incubated for 2 hr at 37°C in 5-10% C02 on a plate shaker (Titertek, Flow Lab¬
oratories, Rickmansworth, Herts, UK). The bacteria were pelleted at 1000 g for
20 min, the supernatant collected and the amount of Lea determinants present
measured by ELISA (see section 5.2.1.2). Two fold dilutions (100 /zl) of the
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Table 5.1: Neisseria meningitidis isolates tested
Number tested Serogroup Serotype Subtype
1 C 2b PI.2
1 C - PI.3
2 B 15 PI.16
1 *NG 15 PI.16
*Non-groupable
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supernatant were added to separate wells for 30 min (as the saliva in the ELISA
method). The amount of Le° epitope left in the supernatant was expressed as a
percentage of the amount of the epitope in the positive control (antigen+PBS).
5.2.4 Inhibition of bacterial attachment to BEC
FITC-labelled bacteria prepared as described in section 4.2.2 (method 2) were
adjusted to 5xl07 bacteria per ml. Bacterial suspensions (0.9 ml) were mixed
with 0.7 ml of the following: affinity purified Lea preparation diluted 1/3 or 1/10
in PBS; undiluted saliva from a non-secretor and saliva diluted 1/10 or 1/100 in
PBS; PBS diluent as a control. After 30 min incubation at 37°C with continuous
shaking, free antigen was removed by addition of 10 ml of PBS followed by
centrifugation at 1000 g for 20 min. The supernatant was removed from the
bacteria by suction to leave a volume of 1 ml. The pellet was resuspended in
this volume. One hundred microlitres of these suspensions were mixed with 200
H\ of BEC from a non-secretor or a secretor to give ratios 1:100 or 1:150 BEC
to bacteria. The attachment assay was performed as described in section 4.2.3.
Samples were tested in duplicate, analysed by flow cytometry (see section 2.7)
and readings were averaged.
5.2.5 Statistics
In some experiments, the results were expressed as percentage of the control,
calculated by the formula: [(test - control) / control] x 100. These values were
used in the Student t-test to calculate p values.
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5.3 Results
5.3.1 Development of an ELISA to measure Lea
The monoclonal anti-Lea used is supplied as a tissue culture supernatant con¬
taining foetal calf serum which can compete with the antibody for space on the
plate. Therefore, in the first method anti-mouse immunoglobulin was used to
capture the mouse monoclonal anti-Lea. By this method, the readings for undi¬
luted saliva and saliva diluted 1/100 from a non-secretor were more than double
the readings for saliva from a secretor at the same dilutions (Figure 5.1). A small
difference was observed when saliva was diluted 103 times but no difference was
found with 104 dilution. The second method used the same mouse monoclonal
anti-Lea but after purification on Synsorb-Lea beads as the first stage capture
antibody. Compared to the previous method, this method gave greater dif¬
ferences in the levels of Lea determinants measured between the secretor and
non-secretor donors (Figure 5.2). This system was more sensitive detecting Lea
determinants in saliva from a non-secretor at the 10-4 dilution and was therefore
used in subsequent experiments for detection of Lea in solutions. Saliva from
a secretor donor, whose red blood cells typed Lea_i_, was used as a negative
control. Low readings were observed for this saliva compared with samples from
the secretor and the non-secretor donors, who expresed Lewis antigens on their
erythrocytes. These readings are probably due to non-specific interactions. In
Figure 5.3, Le° levels in saliva from 12 secretor and non-secretor individuals at
the 10-2 dilution are shown. Non-secretors have significantly (p<0.00l) higher
levels of Lea determinants compared to secretors. At this dilution about 5 times











Figure 5.1: Detection of Lea determinants in saliva from a secretor (red)
and a non-secretor (blue) by ELISA. Monoclonal anti-Lea in culture supernatant
was captured by coating the wells with anti-mouse immunoglobulin antibody.
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Figure 5.2: Detection of Lea determinants by ELISA in saliva from indi¬
viduals of three phenotypes: non-secretor Lewis-positive (blue); secretor Lewis-
positive (red) and a secretor Lewis-negative (green). Synsorb beads were used

























Figure 5.3: Mean levels of Lea detected by ELISA in saliva (diluted 1/100)
from 12 secretor and 12 non-secretor donors. The bars represent ±1SEM.
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5.3.2 Determination of Lea in solution after purification
Saliva from a non-secretor was applied to Sepharose-Lea beads. The eluate from
these beads contained detectable levels of Lea determinants (Figure 5.4). The
level measured in the undiluted preparation was higher than in the original
supernatant, probably as a result of other proteins present in the supernatant
(concentrated saliva) that might interfere with the interaction of antigen and an¬
tibody in the ELISA system. The supernatant from the Sepharose still contained
high levels of Lea determinants and was used in further cycles for purification
of Le° containing molecules.
5.3.3 Adsorption of Lea antigen by bacteria
The ability of bacteria to interact with Le° was investigated by incubating prepa¬
rations containing Lea with bacteria and measuring the remaining amount of Lea
by the ELISA system. After incubation with bacteria, there was a decrease in the
amount of Lea containing molecules in the preparation (Figure 5.5). Statistically
significant differences (p<0.025) were observed at the 1/4 and 1/8 dilutions. The
optical density values for the control ranged between 0.3 and 0.65 depending on
the antigen dilution. The results obtained with the 5 different strains tested were
pooled together since there was no apparent difference in the results obtained








Figure 5.4: Lea determinants detected by ELISA in eluant (red) and


























Figure 5.5: The amount of Lea in supernatant after incubation of Lea
containing preparations with N. meningitidis strains. The amount of antigen
in the supernatant after incubation with bacteria is shown as precentage of the
positive control (antigen without bacteria). Each column represents the average
of 7-13 independent observations, and the bars show ±1SEM.
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5.3.4 Inhibition assay
Incubation of bacteria with preparations of purified molecules containing Lea
determinants resulted in a decrease in bacterial binding to BEC (Table 5.2). At
the higher antigen concentration, a significant reduction in the mean level of
attachment was found at the two ratios of BEC:bacteria tested (1:150, p<0.05,
1:100, p<0.01). When the antigen preparation was diluted 1/10 a significant
decrease (p<0.05) in the amount of bacteria that bound to the cells was observed
at the lower ratio of BEC:bacteria. When bacteria were preincubated with
saliva from a non-secretor no significant decrease in the attachment to BEC
from secretors or non-secretors was found at the three dilutions of saliva used
(Table 5.3).
5.4 D iscussion
In this chapter the hypothesis that the Le° determinant is a receptor for N.
meningitidis was investigated. As a first stage, an ELISA method was developed
for the detection of Le°. With this method, higher levels of Lea determinants
were found in saliva from non-secretors compared with saliva from secretors
(Figure 5.3). Lewis-positive donors (both secretor and non-secretor) were found
to express higher levels of Lea then the Lewis-negative donor (Figure 5.2). These
results are in agreement with the genetic control for the production of Lewis
antigens described in section 1.1.3. According to this model, since the Se enzyme
is not present in non-secretors, the fucosyltransferase coded for by the Le gene
acts on precursor Type 1; and, therefore, only Le° is produced. In contrast,
both enzymes are present in secretors, and they compete for the same substance
(precursor Type 1). However, the enzyme coded for by the Se gene is more
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Table 5.2: The effect of incubation of bacteria with affinity purified
preparation containing Le3, on the attachment of bacteria to BEC from
non-secretors.




Attachment of bacteria with molecules containing the Le3 determinant is
expressed as a percentage of the attachment of bacteria pretreated with
diluent control. The figures represent the mean of 10 samples +1SEM
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Table 5.3: The effect of incubation of bacteria with saliva from non-




Secretors -8.5+9.3 -16.6+6.4 -12.27+8.1
Non-secretors 30+14 15.35+11.3 3.52+7.9
Attachment of bacteria pretreated with saliva from non-secretor is
expressed as a percentage of the attachment of bacteria pretreated with
buffer. The figures represent the mean of 9 samples + 1 SEM.
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efficient and most of the precursor chain is converted to H Type 1 and then by
the action of the Le enzyme to Le6. When the Le enzyme acts on the precursor
structure before the Se enzyme, small amounts of Lea determinants are produced
in secretors. In secretor Lewis-negative individuals, Se is the only enzyme which
fucosylates precursor Type 1, therefore H Type 1 is produced and no Lewis
determinants are found.
The presence of Le" epitopes after elution from Lea-Sepharose beads was con¬
firmed by the Lea ELISA (Figure 5.4). With the affinity purification technique,
molecules which contain the Lea determinant will be specifically adsorbed onto
the beads coated with anti-Lea. These molecules were then eluted by dissocia¬
tion of the antigen-antibody complex by low pH buffer. Since this determinant
is present on variety of molecules (see section 1.1.3), the eluant does not contain
a purified molecule, but a group of molecules all containing at least one Lea
determinant.
The expression of Lewis determinants on the surface of the BEC could not be
measured (as developed for the H determinants, see section 3.2.1) due to prob¬
lems with the specificity and cross-reactions of the monoclonal and polyclonal
antibodies when used with BEC. However, it has been shown by immunohisto-
chemical methods that Le° determinants are present on BEC of non-secretor,
Lewis positive individuals (Vedtofte, 1985).
In this chapter, bacteria were shown to adsorb molecules containing Lea
determinants (Figure 5.5). The amount of Lea present in the supernatant was
significantly decreased following incubation with bacteria compared with the
amount of Le° in the positive control (no bacteria). These results indicate that
the bacteria have sites on their cell surface that adsorb Lea. Up to 30% of the
determinants present in the solution were adsorbed by the bacteria. Increasing
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the amount of bacteria (up to 100 times) mixed with the same amount of antigen
did not result in further reduction in the level of Lea left in the supernatant (data
not shown). It is possible that for some unknown reason only 30% of the Lea
determinants measured by the ELISA are available for bacterial binding.
In contrast to the inhibition of attachment observed with affinity purified
preparations containing the Lea determinant (Table 5.2), Lea antigen in the
natural soluble form, non-secretor saliva, failed to inhibit bacterial binding to
non-secretors cells (Table 5.3). This suggests that this antigen might be an
attachment site on epithelial cells, but its presence in secretions of non-secretors
does not provide protection against colonization of the cells by these bacteria.
The difference in the action of the antigens in the two preparations might be
due to difference in the viscosity and/or purity. Saliva, which failed to inhibit
attachment, is more viscous than the preparations obtained from the Sepharose
beads. This could interfere with the ability of the Lea antigens to interact with
the bacteria.
In this chapter there are two pieces of evidence to suggest that bacteria
express an adhesin that binds to molecules containing Lea. 1) Affinity puri¬
fied preparations of molecules containing Lea inhibited bacterial attachment to
BEC. 2) Following incubation with bacterial suspensions, the amount of Le° de¬
terminants in the supernatant was reduced. Since the preparation used contains
structures other than the Le° determinants, the results presented suggest rather
than prove that the Lea determinant is a receptor.
Another possibility is that the bacteria bind to an internal structure further
down the carbohydrate chain. The increased susceptibility of non-secretors could
be explained if the receptor is more accessible on non-secretors' cells than on
secretors' cells. It is possible that precursor Type 1 is a receptor for the bacteria.
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In most secretors (90-93%), the precursor chain is di-fucosylated i.e. by the
action of the Se and the Le enzymes. In the same proportion of non-secretors,
only the one fucose molecule is added to the precursor Type 1 chain. If the
precursor chain acts as a receptor for the bacteria, the site is probably more
accessible to the bacteria in the form expressed by non-secretors. In addition,
since only one enzyme fucosylates this precursor chain in non-secretors, it is
possible that more precursor determinants are left un-fucosylated. It has been
shown that E. coli and the Shiga toxin can bind to internally placed Galal-
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The binding of meningococci to epithelial cell surfaces is probably mediated by
macromolecules associated with the bacterial outer membrane. Studies with
human cells, cell lines and organ cultures have implicated three meningococcal
surface components in attachment: pili, heat modifiable outer membrane protein
(protein 5) and the major porin proteins (proteins 2 and 3).
Pili are hairlike surface appendages which radiate several micrometres from
the surface of meningococci. Several studies have implicated pili as a major at¬
tachment ligand of meningococci (Salit and Morton, 1981; Stephens and McGee,
1981; Trust et al., 1983) and gonococci (for a review see Stephens, 1989). Re¬
sults of experiments in which gonococci were chemically modified to alter their
surface charge, suggested that pili participated in the first stage of a two stage
attachment process (Heckels et al., 1976). It was proposed that initially pili are
able to overcome the electrostatic barrier which exists between the negatively
charged surfaces of the bacteria and the host cell. This increases the probability
of a closer approach, leading to a stable adhesion which involves other compo¬
nents of the bacterial surface including outer membrane proteins. This second
stage may occur even when the cell is not pilate. The precise mechanism by
which pili are able to overcome the electrostatic barrier is not clear. One pos¬
sibility suggested by Heckels (1989) is that because of their small surface area,
pili are less sensitive to the electrostatic repulsive forces than the surface of the
bacteria. Pili of meningococci are difficult to maintain and are lost on serial
transfer in vitro (Salit and Morton, 1981).
The meningococcal outer membrane contains from two to five major pro¬
teins when examined by SDS-PAGE. They can be catagorized into five different
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classes according to their apparent molecular weight on SDS-PAGE (for a re¬
view see Frasch et al., 1985). These five major outer membrane proteins can be
grouped into two classes on the basis of their reaction to heat and solubility in
detergents (Frasch and Mocca, 1978). Protein 5 of meningococci was defined
as heat modified protein which is similar biochemically to the heat modified
protein of gonococci (P2). For gonococci, several studies have indicated the
importance of P2 as an attachment ligand (for a review see Stephens, 1989).
The importance of protein 5 in mediating attachment of meningococci is less
well established. Initial reports suggest that this protein is a ligand involved in
meningococcal attachment (Stephens, 1989).
A role for the major porin proteins (protein 2 and 3) in attachment and
invasion was proposed by Lynch et al. (1984). These workers reported that
the porin molecules of gonococci and meningococci interact with a lipid bilayer.
It was proposed that during this process a channel is formed through the lipid
bilayer, that could aid the attachment and invasion process.
In this chapter, an attempt was made to identify the structures on the bac¬
teria and on the carbohydrate chains of the blood group determinants which
interact in a lectin-like manner. Synthetic glycoconjugates carrying blood group
determinants with defined structures were used in an ELISA assay. This method
was used to investigate the interaction of blood group determinants with outer
membrane proteins (OMPs), extracted from N. meningitidis strain C:2b:Pl.2.
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6.2 Materials and methods
6.2.1 Examination of bacteria for pili
The presence of pili on the bacterial surface was examined by negative stain¬
ing. A sample of fixed N. meningitidis (C:2b:Pl.2) was stained with potassium
phosphotungstate (PTA) by the method described in Hayat (1989).
6.2.2 Preparation of outer membrane proteins
N. meningitis (C:2b:P1.2) was grown overnight on MNYC agar in a humidified
atmosphere with 10% C02 at 37°C. Bacteria were harvested into 60 ml of PBS
(pH 7.2) to give a heavy suspension and centrifuged at 2000 g for 20 min. The
bacteria were resuspended in 30 ml of PBS; 6 ml at a time were sonicated on
ice, three times, at an amplitude of 6 microns for 50 sec (MSE, Leicestershire,
UK). Unbroken cells were removed by centrifugation at 3000 g for 20 min at
4°C; and, the total cell envelope fraction from the supernatant was pelleted by
centrifugation at 60,000 g at 4°C for 60 min. The pellet was resuspended in
30 ml of 2% (w/v) sodium N-lauroylsarcosine ('Sarkosyl', Sigma) for 20 min at
room temperature. This detergent selectively solubilizes the inner membrane
from the crude envelope preparations and provides a method for examining the
outer membrane (Hancock and Poxton, 1988). The remaining outer membrane
fraction was pelleted by centrifugation at 60,000 g at 4°C for 60 min, resuspended
in distilled water and stored at -20°C.
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6.2.3 Protein estimation
Protein concentration was determined using the Coomassie brilliant blue assay
(Bradford, 1976).
6.2.4 SDS-PAGE
Proteins were separated by SDS-PAGE using the SDS-discontinuous system of
Laemmli (1970) on a mini-protein II cell (Bio-Rad Laboratories Ltd., Watford,
Hertfordshire, UK). Equal volumes of protein sample and sample buffer were
mixed and heated to 100°C for 3 min. Approximately 20 ng of protein were
applied to each lane and electrophoresis performed at a constant voltage of
100V through the stacking gel (5% acrylamide) and at a constant voltage of
150V through the resolving gel (10% acrylamide). Proteins were visualised by
staining with Coomassie blue (0.5% (w/v) Commassie brilliant blue in 25%
(v/v) propan-2-ol + 10% (v/v) glacial acetic acid) followed by destaining with
10% (v/v) glacial acetic acid. Molecular weight markers (Sigma) in the range
of 26,600 to 180,000 were run in parallel. The proteins were identified by their
molecular weight as defined in Frasch et al., 1985.
6.2.5 Binding of Type 1 blood group determinants to
OMPs
The composition of buffers used in this assay are given in section 2.6. Blocking
buffer and washing buffer given in that section were modified by using gelatin
instead of BSA.
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The wells of polystyrene microtitre plate (M129B, Dynatech, Bellinghurst,
Sussex, UK) were coated overnight at 4°C, with 100 /il of 300 /xg/ml OMPs in
coating buffer. All further procedures were carried out at room temperature.
The wells were washed three times with washing buffer (0.03% gelatin) then
blocked for 60 min with blocking buffer (0.3% gelatin). The blocking buffer was
removed and the wells were washed twice with washing buffer. Fifty microlitres
of sugars conjugated to human serum albumin (HSA) obtained from BioCarb
(Russell Fine Chemicals, Chester, UK) or HSA (cat no. A3782, Sigma) diluted
in blocking buffer (10-50 /xg per well) were added to each well for 120 min. The
synthetic glycoconjugates used were Lacto-N-tetraose (precursor Type 1), Lacto-
N-fucopentaose I (H Type 1), Lacto-N-fucopentaose II (Lewis0) and Lacto-N-
difucohexaose I (Lewis6). After 3 washes, 100 fx 1 of 1/100 dilution of biotinylated
polyclonal chicken anti-HSA (Sera-lab LTD, Sussex, UK) in blocking buffer were
added and incubated for 60 min. Unbound antibody was removed by washing
three times; and, 100 fx\ of 1/100 dilution of streptavidin biotinylated horseradish
peroxidase complex (Amersham, Amersham, UK) in blocking buffer were added
for 30 min. After three washes, 100 fx 1 of substrate solution were added. The
reaction was allowed to develop in the dark for 20 min and stopped by adding
50 fx1 of 12.5% (v/v) H2SO4. The absorbance at 490 nm was measured with a
Dynatech plate reader.
6.2.6 The influence of coating the bottom of the well with
different proteins on the binding of HSA-precursor
Type 1
The wells of a microtitre plate were coated overnight at 4°C with 100 /xl of ei¬
ther OMPs, human transferrin, insulin (bovine pancrease), chicken egg albumin
126
(grade V) or rabbit albumin (all 50 fig per well) in coating buffer. The last
four proteins were purchased from Sigma. All further procedures were carried
out at room temperature. The wells were washed three times, blocked for 60
min and washed twice. Fifty microlitres of Lacto-N-tetraose (precursor Type 1)
conjugated to HSA, HSA diluted in blocking buffer (25 fig per well) or diluting
buffer were added to each well for 120 min. The rest of the assay was carried
out as described in section 6.2.5.
6.2.7 The effect of free sugar on the binding of blood
group determinants to OMPs
The assays used to study the specificity of the binding of the blood group de¬
terminants to the OMPs, are based on the ELISA system described in section
6.2.5. Two assays were used:
Assay 1:
The wells of microtiter plate were coated with OMPs. After washing and block¬
ing, 25 fi\ of 10 mM, 5 mM or 1 mM Lacto-N-tetraose (precursor Type 1) carbo¬
hydrate (BioCarb) (diluted in blocking buffer) or blocking buffer were added to
each well. After 60 min incubation, 25 fi\ of Lacto-N-tetraose (precursor Type
1) conjugated to HSA (BioCarb) or HSA (Sigma) diluted in blocking buffer (25
fig per well), as the negative control, were added directly to each well for 120
min. Detection of bound HSA was carried out as described in section 6.2.5.
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Assay 2:
In this assay, after 1 hr incubation with the free carbohydrate (5 mM, 1 mM
or 0.5 mM), unbound sugar was removed by washing twice in washing buffer.
Then, 50 /zl of precursor Type 1 conjugated to HSA (BioCarb) or HSA (Sigma)
diluted in blocking buffer (25 /xg per well), as the negative control, were added
to each well for 120 min. Detection of bound HSA was carried out as described
in section 6.2.5.
6.3 Results
6.3.1 Electron microscopy of meningococci
Electron microscopy showed that pili were not present on the surface of the
bacteria used in these experiments (Figure 6.1).
6.3.2 OMP profile obtained on SDS-PAGE
SDS-PAGE analysis of the crude 'SarkosyP extract produced a profile typical of
Gram-negative OMPs; there were four to five major OMPs and a further 15-25
minor proteins (Figure 6.2). The three major outer membrane proteins identi¬
fied in this preparation are 1, 2 and 5 characterized by their apparent molecular
weights on SDS-PAGE of 46,000±1,000, 41,000±1,000 and 28,000±1,000 respec¬
tively. These results are in accordance with the type of bacteria used indicating
the presence of a protein 2 and a protein 1.
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Figure 6.1: Electron micrograph showing N. meningitidis C:2b:P1.2.
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Figure 6.2: Separation of outer membrane preparation of N. meningitidis
(C:2b:P1.2) by SDS-PAGE in a 10% gel stained with Coomassie brilliant blue.
The molecular weight markers in lane A and the OMPs in lane B. The identity
of the major outer membrane proteins are shown.
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6.3.3 Binding of blood group determinants to OMPs
Several synthetic glycoconjugates were used to study the binding of blood group
determinants to OMPs in an ELISA system. The antigens are oligosaccharides
purified from human milk and attached to HSA via a spacer (acetylphenylenedi-
amine). The conjugates contain 10-20 molecules of oligosaccharide per molecule
of HSA. As shown in Table 6.1, all the glycoconjugates tested bound to the OMP;
in contrast, HSA did not bind to the OMP under the same conditions. The bind¬
ing of the different determinants could not be compared, since the amount of
oligosaccharides per HSA molecule is different in each preparation. Since the
precursor chain is the common structure in all the glycoconjugates examined, it
was used in the following experiments.
6.3.4 The influence of glycoconjugate concentration on
binding to OMPs
The binding of precursor conjugated to HSA to OMPs was dependent on the
amount of glycoconjugate added (Figure 6.3). Maximum binding was reached
when 40 /ig of antigen per well were used. A point around the middle of the
slope (25 [ig per well) was used in the following assays.
6.3.5 Binding of a glycoconjugate to different proteins
The ability of precursor-HSA to bind to several proteins in the ELISA system
was examined, to determine whether the binding of this glycoconjugate is specific
to OMPs. As shown in Figure 6.4, with the glycoconjugate, positive readings
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HSA-Precursor Type 1 0.495
HSA-H Type 1 0.426
HSA-Lewisa 0.356
HSA-Lewisb 0.597
The binding of human serum albumin (HSA) and HSA conjugated with
blood group determinants to OMPs of meningococci. The results are
expressed as optical density (O.D) as measured by an ELISA plate reader at Wor<v
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Figure 6.3: Binding of precursor-HSA glycoconjugate to OMPs of N. menin¬
gitidis. Concentration '0' indicates the presence of unconjugated HSA at 50
yug/well.
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were found for three of five proteins tested: the OMPs, transferrin and rabbit
albumin. For the last two, positive readings were obtained for the two controls,
which indicates that the anti-HSA used probably cross-reacts with the proteins
on the bottom of the plate. In contrast, the negative controls for the OMPs were
both negative, indicating that the positive reading obtained is due to a specific
binding of the glycoconjugate to the OMPs.
6.3.6 The influence of free oligosaccharide on the binding
of glycoconjugate to the OMPs
The precursor Type 1 oligosaccharide was used to study the effect of free oligosac¬
charide on the binding of the same oligosaccharide conjugated to HSA. When
the free saccharide was present during the incubation of the glycoconjugate with
the OMPs an increase was found in the amount of glycoconjugate bound (Fig¬
ure 6.5a). This increase was directly proportional to the amount of saccharide
added up to 5 mM. If unbound saccharide was removed before the addition of
the glycoconjugate then no apparent effect on the binding of the glycoconjugate
was found (Figure 6.5b).
6.4 Discussion
In this chapter an attempt was made to characterize the meningococcal surface
adhesins and the structure in the blood group determinants which might be a
receptor on the host cell. The outer membrane proteins were extracted from
the strain of N. meningitidis used in the previous chapters. As indicated by the












Figure 6.4: The binding of precursor-HSA glycoconjugate (detected by anti-
HSA) to OMPs of N. meningitidis (l), human transferrin (2), bovine insulin (3),
chicken albumin (4) and rabbit albumin (5). The red column is the reading in
the presence of precursor-HSA glycoconjugate. The HSA and PBS controls are
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Figure 6.5: The effect of the oligosaccharide on the binding of precursor-
HSA glycoconjugate to OMPs: (a) in the presence of oligosaccharide during
the binding and (b) when unbound oligosaccharide was removed before the ad¬




other then pili on the bacterial outer membrane must be considered, to explain
the results of the previous chapters which suggested a role for Le" in bacterial
binding.
The importance of OMPs other than pili in the attachment of gonococci
and meningococci has been demonstrated in several studies. More information
is available on these interactions for gonococci than meningococci. In a recent
report, in vitro studies indicated that both pilate and nonpilate gonococci adhere
to and were internalized by tissue culture cells with equal efficiency (Shaw and
Falkow, 1988). In another study, a set of glycolipid receptors on epithelial
cells that are recognized by both pilate and nonpilate variants of gonococci
have been identified (Deal et a/., 1988). These glycolipids share lactose as their
core sugar. Binding to these structures was demonstrated to be independent of
pili and protein 2 expression. The bacterial gene that codes for the ligand was
recently identified and the ligand was observed to be a 36 kD surface protein not
associated with the pilus (Paruchuri et al., 1990). Very little is known about the
role of OMPs of meningococci other than pili in mediating attachment to host
cells. However, the role of these proteins is not in doubt since attachment was
demonstrated in nonpilate bacteria as well as pilate variants. A role for the heat
modifiable protein (protein 5) was reported for urogenital meningococci strains
(Hugman and Danielsson, 1989). They observed that these strains attached
significantly more efficiently to vaginal epithelial cells in the presence of the
heat modifiable proteins.
In this study the OMPs extracted from meningococci and attached to a solid
matrix were found to bind synthetic glycoconjugates which carry Type 1 blood
group structures. The importance of the presence of the carbohydrate chain for
this interaction is indicated by the negative result obtained when HSA without
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a saccharide moiety was added.
When the binding of the precursor-HSA to proteins, other than OMPs',
attached to the solid matrix was examined, two proteins showed positive in¬
teraction (Figure 6.4). This interaction was not specific, as indicated by the
negative controls which gave similar readings as the test. These results were not
unexpected since transferrin is a human serum protein which might have been
injected into the chicken as a contaminant of the HSA; and albumin from the
rabbit is probably similar to human albumin since both are mammals.
From these results it is proposed that the carbohydrate moiety is the struc¬
ture on the glycoconjugate that binds to the OMPs in the ELISA system. The
common structure on all glycoconjugates tested is the Type 1 precursor chain,
therefore, this structure was used in additional assays. The free precursor Type
1 oligosaccharide failed to inhibit the binding of precursor Type 1 glycoconjugate
to the OMPs. In fact, an increase in the binding of the glycoconjugate was found
in the presence of the oligosaccharide. This effect resembles an allosteric effect
for enzymes in which an enzyme possesses at least two spatially distinct binding
sites on the protein molecule: the active site and the regulatory site. Binding of
a molecule to the regulatory site produces a change in the active conformation so
that activity at this site may be increased (see Newsholme and Start, 1974). In
our system, it might be that the protein in the OMPs preparation which binds
the glycoconjugate has an additional site which binds free saccharide. Binding
of the free saccharide might cause a conformational change that allows higher
affinity binding of the glycoconjugate. An increase in the glycoconjugate binding
to the OMPs was not demonstrated when the free oligosaccharide was removed
before the HSA-precursor was added. This could be due to low affinity binding
of the free saccharide to the OMPs. To further examine the specificity of this
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effect monosaccharides and oligosaccharides other than precursor Type 1 chain





Detailed discussion of the results has been given at the end of each chapter.
The objective of this chapter is to provide more general conclusion to this study,
point out limitations in the experimental methods used and prospects for further
research.
Non-secretors of ABH blood group determinants are more susceptible to
several infectious diseases including meningococcal meningitis and are over-
represented among carriers of N. meningitidis (see section 1.2.3 and 1.2.4). The
mechanisms underlying these observations are not known. In this study an at¬
tempt was made to identify some of the interactions between host and parasite
that contribute to these epidemiological observations. The study is based on
hypotheses proposed to explain the association between non-secretion of blood
group antigens and susceptibility to infectious diseases. Both hypotheses suggest
that differences between secretors and non-secretors in the expression of carbo¬
hydrate structures on their epithelial cells result in differences in the degree of
colonization. These hypotheses are supported by increasing evidence that car¬
bohydrate structures on cell surfaces act as specific receptors for bacteria (see
section 1.4.3). The epidemiological evidence indicates that non-secretors are
over-represented among patients compared with their proportion in the control
populations. However, individuals of both phenotypes, i.e. secretors and non-
secretors, are found among patients, and the proportion of non-secretors with
the disease is not necessarily higher than that of secretors with the disease. This
fact suggests that there are additional mechanisms operating in non-secretors
that make them more susceptible to disease, or that non-secretors are deficient
in a defence mechanism. Since both populations are susceptible to infections
by N. meningitidis, examination of one aspect of the bacterial pathogenesis or
the host immune mechanisms can only be expected to show minor differences
between individuals from the two populations.
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Two structures were investigated in this study as possible receptors for bac¬
terial attachment on the surface of epithelial cells. The H determinant was
suggested to be a receptor on the cells of both secretors and non-secretors. The
presence of this determinant in the secretions of secretors could act as an innate
defence mechanism; the antigen in secretions might bind to adhesin on the bac¬
teria and reduce colonization of cells of secretors. This hypothesis assumes that
secretors and non-secretors are similar with respect to the presence and level of
H determinants on the cell surface. To confirm this assumption, the first stage
in the investigation was to determine the level of the H determinant on epithelial
cells of secretors and non-secretors. In contradiction to the assumption made by
the hypothesis, H was found to be expressed in higher levels on various epithelial
cells from secretors compared with cells from non-secretors (see Figure 3.5). In
subsequent experiments, bacterial attachment to BEC from secretors and non-
secretors was compared. The results obtained did not positively correlate with
the expression of H determinants on the cells. These results rule out H as a
possible receptor for meningococcal attachment.
Lea is another structure suggested to act as a receptor for bacterial attach¬
ment on epithelial cells. This determinant is present at higher levels on cells of
non-secretors; and, if it acts as a binding site, should result in greater bacterial
attachment to cells of non-secretors compared with those of secretors. For the
reasons described in section 4.4, the methods available for studying bacterial
attachment to host cells were not used. Instead, a flow cytometric assay was
developed to measure bacterial binding.
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7.1 Analysis of bacterial attachment by flow
cytometry
The attachment of bacteria to BEC from secretors and non-secretors was com¬
pared by flow cytometry. By using this method most of the disadvantages de¬
scribed for attachment assays were resolved (see section 4.4); however, varia¬
tions between individuals in the expression of blood group determinants and
other factors were difficult to control. In addition, individuals from both groups
are susceptible to colonization by bacteria. Thus, if a blood group determinant
that is present solely on cells of one population is involved in attachment, it
must only be part of the repertoire of receptors available for bacterial binding.
The high variation between individuals and the involvement of more than one
receptor decreases the chances of finding significant differences in bacterial bind¬
ing between secretors and non-secretors. It is encouraging that the differences
obtained by the flow cytometric assay, though not significant at the 95% confi¬
dence level, are significant at the 90% confidence level. Taking into account the
above limitations, the differences observed in attachment strongly suggests, but
do not prove, that cells of non-secretors bind more bacteria.
There are several limitations to the use of flow cytometric analysis of bacterial
attachment to epithelial cells. A higher level of binding to non-secretors' cells
compared to secretors' cells was demonstrated when low ratios of bacteria per
cell were used. A further decrease in the ratio of bacteria per cell might have
resulted in statistically significant differences between the two populations. In
order to distinguish between positive and negative cells with respect to bacterial
binding, there is a need for a certain differential level of fluorescence on the cell
surface. If more than one bacterium has to bind to obtain a positive reading,
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then increasing the intensity of fluorescence might allow the use of lower ratios
of bacteria per cell. However, the sensitivity of the flow cytometer given the
fluorescent dye used, did not allow a further decrease in the ratio of bacteria per
cell.
A further limitation is the inability to express the binding of bacteria to cells
in terms of numbers of bacteria per cell. An attempt was made to determine
the number of bacteria attached to each cell. This information can be obtained
if the mean fluorescence level for one bacterium can be determined. The mean
fluorescence level on the cells (on a linear scale) is directly proportional to the
number of bacteria attached. In principle it should be simple to measure the
fluorescence intensity of a single bacterium; but, the small size of organisms and
problems with aggregation made this difficult to perform. Improvements in the
instrumentation (e.g. diameter of the tip's orifice) or treatment of bacteria to
stop agglutination might help to solve some of these problems.
Although the number of bacteria bound to cells is not known, the attachment
index used implies that more bacteria bind to the cell populations obtained
from non-secretors compared with those obtained from secretors. Higher level
of binding to non-secretors cells can be explained by: 1) more receptors available
on these cells for specific interactions or 2) higher affinity interactions between
binding sites on non-secretors cells and an adhesin on the bacteria. In the
first case, Lea can be suggested as a receptor on the cells, since this antigen
is expressed in higher levels on cells of non-secretors compared with cells from
secretors (see section 1.1.3). In the second, the inner carbohydrate chain of the
Type 1 blood group antigens (the precursor Type 1 chain) could be suggested
as a receptor. Differences between secretors and non-secretors in the level of
glycosylation of the Type 1 precursor structure might result in differences in
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its accessibility for bacterial adhesins. This in turn could effect the affinity of
interactions with this receptor. In both cases, carbohydrate structures on the
cells are suggested to act as receptors for bacterial binding. The specificity of
the interaction between the bacteria and a carbohydrate on the host cell might
be demonstrated by inhibition of attachment.
7.2 Inhibition of attachment
Two main methods have been used in previous studies to determine the carbo¬
hydrate structure on the host cell involved in bacterial attachment: 1) blocking
the proposed binding sites on the cells with specific antibodies directed against
the antigen that acts as a receptor; and 2) inhibiting the interaction by blocking
the bacterial ligand with a large excess of sugars that are thought to compose
the carbohydrate receptor on the host.
Blocking bacterial binding by antibodies
Monoclonal antibodies against the Lea determinants were tested for their ability
to block bacterial binding, by treatment of BEC with these antibodies prior to
incubation with the bacteria (data not shown). The antibody failed to inhibit
bacterial binding. Enhancement in the binding of bacteria was observed proba¬
bly due to non-specific interactions between the bacteria and the antibody. In
addition, the specificity of the anti-Lea when applied to BEC is in doubt.
Furthermore, it has been argued that inhibition of attachment by antibodies
does not necessarily identify the receptor on the cells (Freter, 1981). In the
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discussion following his lecture, Freter suggested that antibodies might block
attachment by steric hindrance or by other non-specific mechanisms. Hence,
inhibition of attachment by specific antibodies cannot be used to identify the
epitope used as a receptor in bacterial attachment. On the other hand, no
inhibition of attachment when cells are treated with antibodies indicate that
the epitope is not the structure to which the bacteria bind.
Sugar inhibition of attachment
Sugar inhibition studies were successful in the classical case of mannose bind¬
ing bacteria (Ofek et al., 1977) and a number of carbohydrate receptors have
been discovered using this approach (Beachey, 1980). In the present study, a
wide range of monosaccharides failed to inhibit attachment (data not shown).
This phenomenon has been reported elsewhere and discussed by Bock et al.
(1988). In this review, it was suggested that soluble univalent oligosaccharides
for attachment inhibition might inhibit attachment only for binding sites with
relatively high affinity. When the binding is of low affinity, experiments might
produce misleading negative results. Inhibitory substance might be unable to
compete with binding mediated by the presence of multiple receptors on the cell
surface. An example of this is the inability to inhibit the specific interaction
between Shiga toxin, produced by Shigella dysenteriae type 1, and Galal-4Gal
by a high concentration of free disaccharide. In contrast, the disaccharide cou¬
pled multivalently to bovine serum albumin gave a 50% inhibition at a low level
of saccharide. The use of multivalent glycoconjugates (glycoproteins or glycol-
ipids) might result in micellar formation which is difficult to control (Bock et
al., 1988). This in turn might produce false positive or false negative results
depending on exposure of hydrophobic surfaces or masking of binding epitopes.
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Inhibition of meningococcal attachment to BEC
In the experiments described in chapter 5, affinity purified preparations con¬
taining Lea determinants were used for inhibition of meningococcal attachment.
Although the Lea determinants in these preparations are probably in the multi¬
valent form, the results, though statistically significant, did not indicate a high
level of inhibition (12.9±4.9%). The results do not conclusively indicate a role
for Le° determinants in the attachment of N. meningitidis. Another major prob¬
lem with the interpretation of these results is the impurity of the preparations
used. The method used for obtaining these preparations selects for antigens
containing Lea determinants as part of the molecule. The backbone molecules
which express these determinants will be different and the effect of the other
structures on bacterial attachment cannot be ruled out. Only late in the study
did the antigens being investigated become commercially available in a pure
form. Due to their high cost, they could only be used in a limited number of
experiments. The inability to inhibit bacterial attachment with free saccharides
while achieving inhibition with preparations containing Le°, suggests that if Lea
determinants are involved in specific interactions with bacteria they are of a low
affinity. It has been proposed that low affinity binding might have been selected
for in some ecological niches to avoid inhibition by free oligosaccharides (Bock
et al., 1988). Free oligosaccharides, including blood group structures, are known
to be present in secretions. They may also be present at the target cell surface
as a result of physiological enzymatic degradation (Bock et al., 1988).
Bacterial attachment was inhibited by partially purified preparations con¬
taining Lea determinants (Table 5.2). The high levels of Lea in secretions of
non-secretors (see figure 5.3) raises the possibility that this determinant in mu¬
cus could block attachment to epithelial cells, thereby reducing colonization of
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non-secretor cells in vivo. However, saliva from a non-secretor donor failed to
inhibit meningococcal attachment to BEC (see Table 5.3). This may indicate
that if Lea is a receptor, then the bacteria cannot interact with this structure
in secretions (see section 5.4). Even if it does interact with Lea in secretions, it
should be stressed that, although association with receptors in mucus is gener¬
ally regarded as a mechanism that reduces bacterial colonization, this need not
always be the case. An alternative possibility will be discussed in the following
section.
7.3 The role of mucus in bacterial colonization
Mucus is a secretion that covers most epithelial cell surfaces. It consists of very
large and complex glycoproteins (mucins), in which the carbohydrate fraction
is 70%-90% of the dry weight. On some mucosal surfaces, such as those of
the gastro-intestinal tract and respiratory tact, the mucus is thought to form a
major barrier against penetration of bacteria to the level of the epithelial cells.
Adherence of bacteria to the mucus layer overlying the epithelial cells might
be to the advantage of the host in the presence of a functioning mucociliary
clearance system.
The bronchial tree is protected against inhaled particles, including bacteria,
by the mucociliary system. This is composed of a mucus layer covering cilia
which are hair-like structures. Inhaled particles stick to the mucus surface and
are moved toward the back of the throat by the coordinated beating of the
cilia. If this system malfunctions, then trapping of bacteria in the mucus gel
may be the first step towards colonization. In the case of N. meningitidis,
damage to ciliary activity was noted early in the course of infection of human
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nasopharyngeal tissue in organ culture (Stephens et al., 1987). The damage
to the ciliated cells was not associated with the attachment of meningococci to
these cells. It has been suggested that N. meningitidis damages ciliated epithelial
cells indirectly by release of lipopoh^accharides (LPS), peptidoglycan monomers
or possibly other toxins from the bacteria. In addition, bacterial infections of
the lower respiratory tract often occur following viral infection (see Wilson and
Moxon, 1988). Several mechanisms have been suggested to explain potentiation
of bacterial infection by viruses including loss of ciliated epithelium (Wilson
et al., 1987). Exposure to cigarette smoke is one of the environmental factors
associated with carriage of N. meningitidis (Blackwell et al., 1990) and damage
of cilia activity (see Wanner, 1990). Thus, in meningococcal infection, if the
ciliary activity has been damaged by the release of endo-toxins, viral infection
or by passive or active exposure to cigarette smoke, binding of the bacteria to
the mucus layer could be an advantage to the bacteria. Thus, specific interaction
between N. meningitidis and Lea determinants in mucus of non-secretors might
enhance colonization.
7.4 Adsorption of antigens by meningococci
Affinity purified preparation containing the Lea determinants were used in an¬
other assay in which the presence of binding sites for Lea on the bacteria was
examined (see section 5.3.3). In this study a reduction in the amount of Lea de¬
terminants present in solution was found after incubation with bacteria. These
results are difficult to interpret since, as discussed above, the preparation is
not homogeneous with respect to its chemical make up. However, when a simi¬
lar test was performed with a preparation containing H determinants (prepared
from saliva of a secretor Lewis-negative individual), no decrease in the amount of
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antigen detected in solution was found (data not presented). Since the source of
antigens is similar (saliva), the molecules present in the Le° and H preparations
should be similar apart from the presence of these blood group determinants
as part of the macromolecules. The results suggest that the bacteria have a
receptor that can bind to the Le° epitope but not to H. These results are in
agreement with those obtained in the attachment study (section 4.4). Direct
detection of the Lea epitopes on the bacteria could confirm specific binding.
However, detection of bound Lea by monoclonal antibody was not attempted
because the paratope and the bacteria would be competing for the same site
on the blood group antigen. In addition, detection of the Lea determinant by
antibodies will not serve as direct evidence that it acts as a binding site, since
the bacteria could bind through another structure on the same macromolecule.
The inability of bacteria to adsorb more than 30% of the antigen present
in the solution, even with increased amounts of bacteria, is difficult to explain.
It is possible that for some reason only 30% of the Lea determinants measured
by ELISA are available for bacterial binding. This could happen if 30% of the
antigens detected are in the glycolipid form and the rest are glycoproteins or
vice versa. If the bacterial binding site is influenced by the molecule carrying
the carbohydrate chain, it is possible that the bacteria is limited to binding to
glycolipids. In this case only 30% of the determinants detected by the ELISA
could be adsorbed by the bacteria. The involvement of the carrier molecule in
the bacterial binding site have been suggested for E. coli attachment to antigens
with blood group determinants (Rosenstein et al., 1988). In this study free
carbohydrate structures failed to inhibit bacterial binding to glycoconjugate
carrying the same carbohydrate chain. The authors, therefore, suggested that
the adhesive specificity involves both the saccharide and lipid moiety.
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7.5 Precursor chain as a possible receptor
As was suggested in section 5.4, precursor Type 1 might act as a receptor for
bacterial binding. This structure is less fucosylated in non-secretors compared
with secretors; and therefore, it might be more accessible in non-secretors for a
bacterial adhesin. Differences in the strength of bacterial binding to glycoconju-
gates with different blood group determinants on a Type 1 precursor chain have
been reported (Rosenstein et al., 1988). Modification of the precursor struc¬
ture by addition of monosaccharide (in H and Le6 determinants) interfered with
binding of E. coli. Thus, Rosenstein et al. (1988) predicted that the secretor
gene and the blood group genes that code for glycosyltransferases would influ¬
ence bacterial binding and hence susceptibility to colonization. In experiments
performed in this study, precursor Type 1 conjugated to HSA bound to OMPs
obtained from one strain of N. meningitidis (section 6.3.3).
If the precursor chain is a receptor for bacteria, then a form of defence mech¬
anism will be to produce glycosyltransferases that will modify this structure,
thereby interfering with bacterial attachment to the receptor. The induction
of fucosyltransferase activity a few days after conventionalization of germ-free
mice has been reported (Umesaki et al., 1982). On the other hand, production
of enzymes by the bacteria that can degrade monosaccharides on the extended
precursor chain might be a virulence factor facilitating colonization. Evidence
for this process has been reported by Larson et al. (1987), who studied the gly-
cosphingolipids of meconium (the first sterile stool of newborns) and faeces of
newborns and young children. In this study they found that ABH blood group
activity rapidly diminished after the first few days of life parallel to bacterial
colonization of the intestines. The pattern of undegraded glycosphingolipids
seen in meconium was found to be replaced mainly by the precursor chain (lac-
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tosylceramide).
Binding to an inner structure rather than to the terminal part of a carbo¬
hydrate chain has been reported for E. coli and Shiga toxin. The binding site,
identified as Galal-4Gal/3, is situated in the inner core of the carbohydrate
chain (for a review see Bock et al., 1988). Binding of microorganisms to internal
structures might have been selected for in evolution to avoid variations in the
terminal parts of the carbohydrate chain, as in blood group determinants.
7.6 A new hypothesis to explain differential sus¬
ceptibility dependent on secretor status
Degradation of carbohydrate structures described in the previous section might
have an additional function in supplying growth substances for the bacteria. If
the bacterial enzymes have a higher affinity for blood group determinants found
in non-secretors (i.e. Lea) than for determinants expressed in secretors (Le6),
this suggests two susceptibility factors. The first is that non-secretors could
provide the bacteria with a better "growth medium" compared with secretors.
In addition, as a side effect, if the bacterial enzyme which degrades the blood
group determinant is membrane bound, it can act as an adhesin in the process
of colonization.
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7.7 Applications of identification of host recep¬
tors and bacterial ligands
Clinical diagnosis and prevention of bacterial infection could be supplemented
by knowledge of the specific receptors involved in bacterial binding. For diagnos¬
tic purposes, synthetic receptor analogues with an optimized binding property
could be linked to a solid matrix for selective uptake and detection of a bacte¬
rial ligand from infected samples (urine, blood, etc.). The ideal approach to the
control of meningococcal infections would be to block their initial attachment
to the mucosal surfaces thereby preventing colonization. Interference with bac¬
terial adherence can be achieved by actively inducing an inhibitory substance
(i.e. vaccination) or by passive administration of an inhibitory substance (i.e.
receptor analogue).
Non-immunogenic methods such as the use of potent receptor analogues to
inhibit ligand attachment to mucosal membrane have been suggested in the case
of oral cavity and gastro-intestinal tract infections (Freter, 1980). Since most
natural foodstuffs contain sugars, polysaccharides, glycoproteins and glycolipids,
many of them have been suggested as a method for reducing bacterial binding
to mucosal surfaces when lectin-like interactions are involved. Since the site of
meningococcal colonization is the nasopharynx and oropharynx, this approach
is of limited use unless the substances could be applied as aerosols or droplets.
Vaccines have been used as means of preventing the spread of meningococcal
infection. The meningococcal polysaccharide vaccines have several limitations
discussed in section 1.3. These vaccines were found to be highly effective at pre¬
venting meningococcal disease, but they are much less effective at eliminating
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carriage and at preventing nasopharyngeal colonization (reviewed by Green¬
wood, 1984). Thus, the methods of vaccination available cannot be relied on to
stop the spread of epidemic strains.
Prevention of initiation of infection by microorganisms that use the mucosal
surface as their primary location of attachment (such as N. meningitidis) is asso¬
ciated with secretory IgA (slgA). slgA was demonstrated to be effective in cross-
linking particles, preventing adhesion and inactivating toxins (reviewed by Hone
and Hackett, 1989). Stimulation of slgA requires the administration of antigen
to mucosal surfaces since an effective slgA response is not provoked following
parenteral vaccination. Therefore, the approach available for meningococcal vac¬
cination, i.e. polysaccharide vaccine given parenteraly, does not stimulate slgA
which is the most important type of antibody in prevention of colonization. In
addition, since polysaccharides are T-independent antigens, they are ineffective
at inducing immunogenic memory. Thus, booster immunization does not result
in an accelerated and enhanced antibody response. For these reasons, many
groups have turned their attention towards the development of other types of
meningococcal vaccines and other methods for administration.
One method that has been studied is oral vaccination which has been shown
to be effective in reducing infection and colonization by Vibrio cholerae (reviewed
by Hone and Hackett, 1989). Oral administration of a vaccine stimulates pri¬
marily the mucosal immune system of the gastro-intestinal tract. It has been
established that induction of local antibody production at a given mucosal site
does not require the application of the immunizing antigen to the same site
(see Underdown and Schiff, 1986). Hence, oral administration of meningococcal
vaccine will induce local immunity in the oropharyngeal mucosa.
Bacterial surface antigens as oral vaccines has been examined for enterotox-
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igenic strains of E. coli (del la Cabada et al., 1981). Rabbits orally immunized
with purified CFA/I (colonization factor I) fimbriae of E. coli were protected
against challenge with virulent strains expressing homologous fimbriae. This
protection correlated with increased levels of anti-CFA/I slgA. In the search
for new antigens for a meningococcal vaccine, an outer-membrane protein vac¬
cine has been used in a clinical trial in South Africa (reviewed by Greenwood,
1984). This vaccine was effective in reducing carriage with organisms of ho¬
mologous serotypes, but the number of clinical cases occurring in the test and
control groups was too low to allow conclusions to be drawn about its efficacy
in preventing clinical disease.
An alternative method for stimulating a local mucosal immunity has been
used for the prevention of viral infections of the respiratory tract mucosa. In-
ternasal administration of a live attenuated influenza virus has been used ex¬
tensively in the United States and the Soviet Union (Weir, 1988). This method
which was found to effectively produce neutralizing slgA antibodies might be
useful as a means of delivering meningococcal vaccines.
The epidemiological studies and the results of this current investigation have
indicated possible candidates for a meningococcal vaccine and the population at
most risk. It appears that non-secretors are more susceptible to meningococcal
infections because they are more likely to carry the bacteria. This differen¬
tial susceptibility does not appear to be associated with a specific serotype or
serogroup of meningococci (see section 1.2.4). In addition, the results of the
experiments presented in section 5.3.3, suggest that adsorption of molecules
containing Lea is not limited to a particular isolate of these bacteria. Further
studies aimed at identifying the particular receptor on non-secretors might pro¬
vide a tool for isolating the ligand on the bacteria. Such a ligand would be
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a suitable candidate as a vaccine, since it is probably common to a variety of
meningococcal strains and since receptor-binding properties of bacteria are likely
to be highly conserved. In addition, since this ligand is probably a protein, it
will provoke a T-dependent immune response which will ensure the production
of immunogenic memory.
This study presents preliminary evidence for a role for blood group deter¬
minants as receptors for meningococcal attachment. The results highlight the
complexity of studying host factors which play a role in the differential suscep¬
tibility of non-secretors. In order to draw definite conclusions as to the role of a
given structure in bacterial attachment, further studies should make more use of
commercially available purified or synthetic antigens. This approach was applied
in experiments described in chapter 6. Extending these investigations could lead
to the identification of the cell surface receptor(s) and bacterial ligand(s), which
might lead to a new type of meningococcal vaccine.
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Abbreviations
BEC Buccal epithelial cells
BSA Bovine serum albumin
DPBS Dulbecco's phosphate-buffered saline
ELISA Enzyme linked immunosorbent assay
FITC Fluorescein isothiocyanate




MNYC Modified New York City
NPC Nasopharyngeal cells
OMP Outer membrane protein
OPC Oropharyngeal cells
PBS Phosphate-buffered saline
SDS-PAGE Sodium dodecyl sulphate-polyacrylamide gel electrophoresis
Se Secretor
IJEAI Ulex europaeus lectin I
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